{"gene":"BOK","run_date":"2026-06-09T22:02:45","timeline":{"discoveries":[{"year":1997,"finding":"BOK (Bcl-2-related ovarian killer) was identified as a pro-apoptotic BCL-2 family member containing BH1, BH2, and BH3 domains and a C-terminal transmembrane region but lacking the BH4 domain. In yeast two-hybrid assays, BOK interacted selectively with Mcl-1, BHRF1, and Bfl-1, but not with Bcl-2, Bcl-xL, or Bcl-w—a heterodimerization pattern distinct from other pro-apoptotic members (Bax, Bak, Bik). Overexpression of BOK in mammalian cells induced apoptosis that was blocked by P35 and suppressed by co-expression of Mcl-1 or BHRF1 but not Bcl-2.","method":"Yeast two-hybrid, mammalian cell overexpression, co-expression rescue assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal yeast two-hybrid plus functional mammalian cell rescue, foundational paper replicated by multiple subsequent studies","pmids":["9356461"],"is_preprint":false},{"year":1998,"finding":"A naturally occurring splicing variant of BOK (Bok-S) with a 43-residue deletion fusing the N-terminal half of BH3 to the C-terminal half of BH1 retained apoptosis-inducing activity but lost the ability to dimerize with anti-apoptotic proteins in vitro. Additional BH3 domain mutations in Bok-L also abolished heterodimerization without impairing pro-apoptotic function, indicating that heterodimerization with anti-apoptotic proteins is not required for BOK-mediated cell killing.","method":"Site-directed mutagenesis, in vitro binding assay, mammalian cell overexpression/apoptosis assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro binding assay combined with mutagenesis and cell-death assays in a single focused study","pmids":["9804769"],"is_preprint":false},{"year":2004,"finding":"In human neuroblastoma and breast cancer cells, DNA damage-induced apoptosis required new protein synthesis, p53 accumulation, and p53-dependent induction of BOK and NOXA genes, with cytochrome c translocation not dependent on BAX. This placed BOK downstream of p53 and upstream of cytochrome c release in the DNA-damage intrinsic apoptosis pathway.","method":"Protein synthesis inhibition, p53 activation assays, cytochrome c translocation assay, gene expression analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, pathway placement by inhibitor and expression analysis without direct BOK KO validation","pmids":["15102863"],"is_preprint":false},{"year":2006,"finding":"BOK expression is cell cycle-regulated: Bok RNA is low in quiescent cells and rises upon serum stimulation. The mouse Bok promoter contains a conserved E2F binding site (−43 to −49); serum-dependent activation requires this site, and endogenous E2F1 and E2F3 associate with the Bok promoter in vivo by chromatin immunoprecipitation.","method":"RT-PCR, luciferase reporter assay, chromatin immunoprecipitation (ChIP), promoter cloning","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus luciferase reporter with site-specific mutation, single lab","pmids":["16772296"],"is_preprint":false},{"year":2006,"finding":"Human BOK contains a leucine-rich nuclear export signal (NES) within its BH3 domain. BOK is present in both nucleus and cytoplasm; treatment with leptomycin B (Crm1 inhibitor) increases nuclear BOK. Crm1 co-immunoprecipitates wild-type BOK but not a NES-mutant BOK. Mutation of the NES increases nuclear localization and apoptotic activity, indicating that nuclear export of BOK is a regulated process mediated by Crm1.","method":"Western blot fractionation, leptomycin B treatment, site-directed mutagenesis, co-immunoprecipitation, immunocytochemistry","journal":"Molecular carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus mutagenesis plus localization, single lab","pmids":["16302269"],"is_preprint":false},{"year":2013,"finding":"Endogenous BOK localizes predominantly to the membranes of the Golgi apparatus and ER (and associated membranes) via a C-terminal tail-anchor transmembrane domain. Overexpression of full-length BOK causes early fragmentation of ER and Golgi compartments. BOK-deficient cells showed abnormal responses to the Golgi/ER stressor brefeldin A. Enforced BOK expression in BAX/BAK-proficient cells activates the intrinsic apoptotic pathway, but BOK fails to kill cells lacking both BAX and BAK.","method":"Subcellular fractionation, immunofluorescence/confocal microscopy, BOK truncation constructs, Bok-/- MEFs, apoptosis assays","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal localization methods plus functional rescue experiments, replicated in subsequent studies","pmids":["23429263"],"is_preprint":false},{"year":2013,"finding":"BOK binds strongly and constitutively to inositol 1,4,5-trisphosphate receptors (IP3Rs) in cells. BOK preferentially binds IP3R1 and IP3R2 but barely IP3R3. The binding site maps to a small region within the IP3R coupling domain (amino acids 1895–1903 of IP3R1). Essentially all cellular BOK is IP3R-bound in cells expressing substantial IP3Rs. BOK protects IP3Rs from proteolytic cleavage (by chymotrypsin in vitro and by caspase-3 in vivo) and regulates IP3R expression levels. Persistent IP3-dependent signaling triggers co-degradation of BOK and IP3R via the ubiquitin-proteasome pathway.","method":"Co-immunoprecipitation, in vitro pulldown, chymotrypsin protection assay, caspase-3 cleavage assay in apoptotic cells, IP3R truncation mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, domain mapping, in vitro protease protection assay, in vivo caspase-3 cleavage assay, multiple orthogonal methods in one study","pmids":["23884412"],"is_preprint":false},{"year":2013,"finding":"Loss of BOK combined with loss of BAX in Bok-/-Bax-/- female mice resulted in abnormally increased numbers of oocytes from different developmental stages in aged animals, indicating an overlapping pro-apoptotic function of BOK and BAX in age-related follicular atresia. Combined loss of BOK and BAK showed no noticeable phenotypic defects.","method":"Genetic knockout mouse model, histological analysis of ovaries","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined phenotypic readout in compound knockout mouse, single lab","pmids":["23744350"],"is_preprint":false},{"year":2015,"finding":"Bok-/- cells are selectively defective in apoptotic responses to ER stress stimuli (thapsigargin, A23187, brefeldin A, DTT, geldanamycin, bortezomib) but not to other apoptotic stimuli (etoposide, staurosporine, UV). BOK's predominant subcellular localization at the ER is consistent with this selective role. BAX and BAK cannot compensate for this ER stress apoptosis defect in BOK-deficient cells. Bok-/- cells also show diminished ATF4 and CHOP activation after ER stress.","method":"Bok-/- mouse embryonic fibroblasts, multiple ER stressor treatments, apoptosis assays, unfolded protein response (UPR) activation analysis, in vivo thapsigargin challenge","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined phenotypic readout, multiple stimuli, in vivo validation, replicated across cell types","pmids":["26015568"],"is_preprint":false},{"year":2016,"finding":"BOK is a bona fide effector of mitochondrial outer membrane permeabilization (MOMP) that can trigger apoptosis in the absence of both BAX and BAK. Unlike BAX/BAK, BOK is constitutively active and unresponsive to antagonism by anti-apoptotic BCL-2 proteins. BOK is controlled at the level of protein stability: it is ubiquitylated by the AMFR/gp78 E3 ubiquitin ligase complex and targeted for proteasomal degradation in a VCP/p97-dependent manner. When proteasome function, VCP, or gp78 is compromised, BOK is stabilized and induces MOMP independently of other BCL-2 proteins.","method":"BAX/BAK double-knockout cells, proteasome inhibition, gp78/VCP knockdown, ubiquitylation assay, MOMP assay, apoptosis assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple cell systems, identification of E3 ubiquitin ligase and degradation machinery with functional validation, highly cited","pmids":["26949185"],"is_preprint":false},{"year":2016,"finding":"BOK induces cytochrome c release and apoptosis independently of BAX and BAK in multiple cell systems. Endogenous BOK levels modulate apoptotic responses to chemotherapeutic drugs in ovarian carcinoma cells as shown by RNAi and targeted gene deletion of BOK.","method":"BAX/BAK-deficient cell systems, siRNA knockdown, CRISPR gene deletion, cytochrome c release assay, apoptosis assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal loss-of-function approaches (RNAi + CRISPR), multiple cell systems, single lab","pmids":["27076518"],"is_preprint":false},{"year":2016,"finding":"In neurons, BOK is not required for staurosporine-, proteasome inhibition-, or excitotoxicity-induced apoptosis. Instead, BOK-deficient neurons are more sensitive to oxygen/glucose deprivation and seizure-induced injury. BOK deficiency reduces neuronal MCL-1 protein levels and causes disrupted mitochondrial bioenergetics and calcium homeostasis in response to excitotoxic stimuli, which could be rescued by MCL-1 overexpression. BOK-deficient neurons activate poly ADP-ribose polymerase-dependent cell death.","method":"Bok-/- neurons, single-cell calcium imaging, mitochondrial bioenergetics assay, MCL-1 overexpression rescue, in vivo seizure model, cell death pathway analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (imaging, bioenergetics, rescue) in both in vitro and in vivo neuronal models, single lab","pmids":["27098698"],"is_preprint":false},{"year":2017,"finding":"Recombinant BOK (BOK∆C) permeabilizes liposomes mimicking mitochondrial outer membrane composition, forming large stable toroidal pores. Pore formation is enhanced by cBID and is refractory to BCL-XL. However, isolated mitochondria from Bax-/-Bak-/- cells were resistant to BOK-induced cytochrome c release even in the presence of cBID, suggesting that BOK's direct MOMP activity at native mitochondria requires additional factors or regulation.","method":"In vitro liposome permeabilization assay, isolated mitochondria cytochrome c release assay, recombinant protein, cBID/BCL-XL addition","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified proteins and liposomes, but mitochondrial result was negative/inconclusive, single lab","pmids":["28064468"],"is_preprint":false},{"year":2017,"finding":"DNAJB12 (JB12), an ER-associated Hsp40 protein, is required to maintain BOK at low levels and is detected in complexes with JB12 and gp78. JB12 is degraded by ER-associated degradation complexes (containing HERP, Sel1L, gp78) during severe ER stress. JB12 knockdown leads to BOK accumulation and activation of Caspase 3, 7, and 9, sensitizing cells to proteotoxic agents.","method":"Co-immunoprecipitation, siRNA knockdown, caspase activation assay, proteasome inhibition","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying complex, KD with defined apoptotic readout, single lab","pmids":["28536268"],"is_preprint":false},{"year":2017,"finding":"Myocardin-related transcription factor MAL/MRTF-A directly induces Bok transcription via a CArG-like box in the Bok promoter in an SRF-dependent and actin-regulated manner. Chromatin immunoprecipitation confirms inducible recruitment of MAL and SRF to the Bok promoter. MAL-dependent Bok induction occurs downstream of TNF and staurosporin stimulation.","method":"Luciferase reporter assay, ChIP, actin drug (latrunculin) treatment, siRNA knockdown","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assay with site-specific elements, single lab","pmids":["22185759"],"is_preprint":false},{"year":2018,"finding":"NMR structure of the BCL-2 core of human BOK reveals a conserved BCL-2 architecture with an atypical hydrophobic groove that undergoes conformational exchange. The BCL-2 core of BOK spontaneously associates with purified mitochondria and releases cytochrome c. Alanine substitution of a unique glycine in helix α1 stabilizes BOK and significantly inhibits MOMP, liposome permeabilization, and cell death. Activated BID does not activate WT BOK or the stabilized mutant, supporting a metastability-driven (rather than BH3 ligand-driven) mechanism of BOK activation.","method":"NMR structure determination, thermal shift assay, urea denaturation, in vitro MOMP assay with purified mitochondria, liposome permeabilization assay, alanine mutagenesis, cell death assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR structure plus reconstitution plus mutagenesis in one study, multiple orthogonal methods","pmids":["29768206"],"is_preprint":false},{"year":2018,"finding":"BOK structural analysis reveals close resemblance to BAX and BAK. Triple-knockout (Bok-/-Bax-/-Bak-/-) mice exhibit more severe developmental defects and die earlier than Bax-/-Bak-/- mice, demonstrating that BOK has overlapping roles with BAX and BAK during developmental cell death in vivo.","method":"Structural analysis, triple-knockout mouse generation, developmental phenotype analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — triple-KO mouse with clear developmental phenotype establishing overlapping in vivo function, published in Cell","pmids":["29775594"],"is_preprint":false},{"year":2018,"finding":"The ceramide (CER)/BOK axis promotes mitochondrial fission in preeclamptic placentae. BOK expression is increased by CER 16:0. Loss- and gain-of-function experiments showed BOK positively regulates phospho-DRP1/DRP1 and MFN2 expression and localizes mitochondrial fission events to ER/MAM compartments. The BH3 and transmembrane domains of BOK are required for this regulation of fission.","method":"Loss- and gain-of-function experiments, CER treatment, DRP1/MFN2 expression analysis, transmission electron microscopy, BOK domain deletion constructs","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mutagenesis plus gain/loss of function, defined phenotypic readout, single lab","pmids":["29463805"],"is_preprint":false},{"year":2018,"finding":"The BH3 domain leucine-1 mutation (L70E) in BOK does not block apoptosis induction, but when combined with transmembrane domain deletion, the Bok(L70E)ΔTM double mutant shows enhanced pro-apoptotic activity by abolishing interaction with anti-apoptotic proteins, especially MCL-1. Deletion of the C-terminal transmembrane domain reduces pro-apoptotic function of BOK. The transmembrane domain thus contributes to BOK's interaction with and inhibition by MCL-1.","method":"Site-directed mutagenesis, domain deletion constructs, apoptosis assay, interaction analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis plus functional apoptosis and interaction assays, single lab","pmids":["30127460"],"is_preprint":false},{"year":2019,"finding":"BOK is a positive regulator of uridine monophosphate synthetase (UMPS) activity. BOK expression enhances UMPS enzymatic activity, cell proliferation, and chemosensitivity to 5-fluorouracil (5-FU). Genetic deletion of Bok results in chemoresistance to 5-FU in cell lines and in vivo. Cancers resistant to 5-FU down-regulate BOK expression.","method":"Bok-/- cells and mice, UMPS activity assay, 5-FU sensitivity assay, cell proliferation assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — enzymatic activity assay plus Bok KO mouse model, defined functional readout, single lab","pmids":["31311867"],"is_preprint":false},{"year":2019,"finding":"Deletion of BOK expression by CRISPR/Cas9 significantly reduces mitochondrial fusion rate, resulting in mitochondrial fragmentation. This fragmentation phenotype is reversed by exogenous wild-type BOK and by an IP3R binding-deficient BOK mutant. BOK deletion also enhances mitochondrial spare respiratory capacity and membrane potential. BOK deletion does not alter IP3R-mediated Ca2+ signaling or Ca2+ influx into mitochondria. BOK deletion does not alter responsiveness to various apoptotic stimuli.","method":"CRISPR/Cas9 knockout, mitochondrial morphology analysis, mitochondrial fusion rate assay (photoactivatable GFP), Ca2+ mobilization assay, bioenergetics assay, BOK rescue constructs","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR KO plus multiple orthogonal functional assays plus rescue with domain mutants, single lab, rigorous design","pmids":["30976095"],"is_preprint":false},{"year":2020,"finding":"The transmembrane domain (TMD) of MCL-1 forms homooligomers in the mitochondrial membrane and induces cell death in a BOK-dependent manner. The BOK TMD oligomers localize preferentially to the ER, while heterooligomerization between MCL-1 TMD and BOK TMD occurs predominantly at the mitochondrial membrane. Co-expression of MCL-1 and BOK TMDs increases ER-mitochondrial associated membrane (MAM) contacts. Cancer-associated somatic mutations in MCL-1 TMD alter the TMD interaction pattern.","method":"Split-GFP TMD interaction assay, subcellular localization analysis, BOK-dependent cell death assay, molecular dynamics simulation, mutant analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional interaction assay plus molecular dynamics, defined BOK-dependent phenotype, single lab","pmids":["33093207"],"is_preprint":false},{"year":2021,"finding":"BOK is necessary for baseline mitochondrial calcium levels and stimulus-induced calcium transfer from the ER to the mitochondria. Bok-/- MEFs have decreased proximity of the ER to the mitochondria and altered protein composition of mitochondria-associated membranes (MAMs). Drug-inducible ER-mitochondria linkers can overcome the proximity defect but fail to rescue thapsigargin-induced calcium transfer or apoptosis in Bok-/- cells. A BOK mutant unable to interact with IP3R restores ER-mitochondrial proximity but not calcium transfer, MAM protein composition, or apoptosis, showing that the BOK-IP3R interaction specifically governs calcium transfer.","method":"Bok-/- MEFs, mitochondrial calcium assay, ER-mitochondrial proximity assay (proximity ligation), chemically inducible organelle linkers, BOK IP3R-binding mutant, MAM proteomics, apoptosis assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including inducible linkers and domain-specific mutants, clean KO, functional rescue experiments","pmids":["33691099"],"is_preprint":false},{"year":2021,"finding":"Proximity labeling (TurboID-Bok) revealed that Bok is proximal to proteins involved in mitochondrial fission (e.g., Drp1) and ER-plasma membrane junctions (e.g., Stim1). Among BCL-2 family members, Bok is proximal only to Mcl-1. When overexpressed, Mcl-1 and Bok interact physically and functionally in a manner dependent on the transmembrane domain of Bok. The Bok interactome is largely distinct from those of Mcl-1 and Bak.","method":"TurboID proximity labeling, mass spectrometry, co-immunoprecipitation, transmembrane domain deletion mutants","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proximity labeling plus Co-IP for physical interaction, TMD dependency shown by mutagenesis, single lab","pmids":["34136494"],"is_preprint":false},{"year":2021,"finding":"Bok binds to a largely disordered loop in IP3R1 between α helices 72 and 73 (residues 1882–1957). The high-affinity binding site maps to amino acids 1898–1940 (Kd ~65 nM as measured with purified proteins and IP3R1-derived peptides). Binding is mediated by multivalent interactions with both the central low-disorder region and flanking high-disorder regions. Small deletions in the predicted transient helical elements (residues ~1914–1926) block Bok binding.","method":"Bioinformatic disorder prediction, in vitro pulldown with purified Bok and IP3R1 peptides, IP3R1 deletion/point mutants, membrane recruitment assay in cells","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified proteins, Kd measurement, mutagenesis, multiple orthogonal methods in one study","pmids":["33773141"],"is_preprint":false},{"year":2022,"finding":"SARS-CoV-2 membrane (M) protein stabilizes BOK by inhibiting its ubiquitination and promotes BOK mitochondrial translocation. The endodomain of M protein is required for interaction with BOK. The BH2 domain of BOK is required for interaction with M protein and for pro-apoptotic activity. M protein can induce MOMP-independent apoptosis via BOK in the absence of BAX and BAK. BOK knockout (CRISPR) increases cellular resistance to M protein-induced apoptosis; BOK re-expression restores it.","method":"CRISPR/Cas9 BOK knockout, co-immunoprecipitation, ubiquitination assay, domain deletion mutants, apoptosis assay in BAX/BAK-deficient cells, in vivo lentiviral infection model","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, ubiquitination assay, CRISPR KO rescue, domain mutants, and in vivo validation in a single study","pmids":["35022571"],"is_preprint":false},{"year":2022,"finding":"BOK-deficient cells have an attenuated unfolded protein response (UPR) across all three UPR signaling branches upon ER stress induction. FRAP experiments with GRP78/BiP-eGFP demonstrated that GRP78 motility is significantly lower in BOK-deficient cells, indicating more BiP is bound to unfolded proteins (reduced chaperone availability), establishing BOK as a regulator of ER proteostasis.","method":"UPR reporter cell lines, FRAP microscopy with GRP78-eGFP, Bok-/- neurons and cell lines","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRAP plus functional UPR reporters in KO cells, two orthogonal approaches, single lab","pmids":["36060797"],"is_preprint":false},{"year":2022,"finding":"Endogenous Bok is stable at the ER membrane and its stability is critically dependent on the presence of IP3Rs. In the absence of IP3Rs, endogenous Bok is rapidly degraded by the ubiquitin-proteasome pathway. Proteasome inhibitor-induced apoptosis is not mediated by endogenous Bok. Charged residues in the transmembrane region of Bok affect its stability, ability to interact with Mcl-1, and pro-apoptotic activity when over-expressed. This study reports that endogenous Bok does not play a major role in apoptotic signaling (negative finding regarding BOK as a constitutively active MOMP effector governed purely by proteasomal degradation).","method":"IP3R knockout cells, proteasome inhibition, ubiquitylation assay, Bok stability assays, transmembrane domain mutants, apoptosis assays","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — IP3R KO plus mutagenesis plus proteasome inhibition, multiple orthogonal approaches, single lab","pmids":["36601536"],"is_preprint":false},{"year":2024,"finding":"The transmembrane domain (TMD) of anti-apoptotic BCL-2 interacts with the TMD of BOK at the ER membrane, as demonstrated by split-luciferase assay in living cells and confirmed by molecular dynamics simulations showing stable BOK-TMD/BCL-2-TMD heterotetramers. Mutation of BCL-2-TMD at predicted key residues abolishes interaction with BOK-TMD. Inhibition of BOK-induced apoptosis by BCL-2 depends specifically on their TMD interaction, revealing a novel TMD-mediated apoptosis regulation mechanism.","method":"Split luciferase assay in living cells, molecular dynamics simulation, site-directed mutagenesis of BCL-2-TMD, subcellular localization, apoptosis assay","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — reconstitution of TMD interaction in cells, MD simulation structural validation, mutagenesis, functional apoptosis assay, multiple orthogonal methods","pmids":["39048751"],"is_preprint":false},{"year":2025,"finding":"BOK directly suppresses IP3R1-mediated Ca2+ mobilization. Specifically, Bok accelerates the post-maximal decline in GPCR-induced cytosolic Ca2+ by suppressing IP3R-dependent Ca2+ release from the ER. This effect requires the Bok-IP3R interaction (only seen with IP3Rs that bind Bok, e.g., IP3R1). Ser-8 phosphorylation of BOK by cAMP-dependent protein kinase weakens Bok-IP3R1 interaction and reverses Bok's suppressive effect on IP3R1-mediated Ca2+ mobilization.","method":"Fluorescent Ca2+-sensitive dye and genetically encoded Ca2+ sensor assays, PKA phosphorylation of purified proteins, mass spectrometry, phosphomimetic substitution (Ser-8), GPCR agonist stimulation, IP3R1-expressing cell systems","journal":"Cell communication and signaling","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro PKA assay with purified proteins plus multiple functional Ca2+ assays in cells plus phosphomimetic mutagenesis, multiple orthogonal methods","pmids":["39810210"],"is_preprint":false},{"year":2017,"finding":"BOK expression is negatively regulated post-transcriptionally by TRIM28 binding to conserved AU/U-rich elements in the human BOK 3' UTR. TRIM28 was identified as a key regulatory component by proteomics approaches, and its recruitment to the 3' UTR results in dramatic reduction of BOK expression.","method":"Proteomics/mass spectrometry identification, RNA pulldown, reporter assay, TRIM28 knockdown","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proteomic identification plus functional RNA pulldown and reporter assay, single lab","pmids":["30471638"],"is_preprint":false},{"year":2017,"finding":"miR-296-5p regulates BOK expression by binding to its 3' UTR in breast cancer cells. Ectopic BOK expression induces MCL-1 upregulation, while MCL-1 silencing reduces BOK levels, forming a regulatory feedback loop. Glycogen synthase kinase (GSK3) α/β interacts with BOK and regulates its protein level post-translationally.","method":"3'-UTR luciferase reporter assay, co-immunoprecipitation (GSK3-BOK), BOK/MCL-1 siRNA knockdown, Western blot","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — 3'-UTR reporter plus Co-IP, multiple interactions identified but single lab with limited mechanistic depth per interaction","pmids":["29156771"],"is_preprint":false},{"year":2025,"finding":"BCL-B interacts directly with BOK and can mitigate BOK-mediated cell death. This interaction promotes sublethal MOMP, generating apoptosis-flatliners that serve as drug-tolerant persister cells with enhanced invasiveness via EMT.","method":"Co-immunoprecipitation, sublethal MOMP assay, apoptosis-flatliner identification, EMT assay","journal":"Cells","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Co-IP plus functional assays, single lab, limited mechanistic detail in abstract","pmids":["39996719"],"is_preprint":false},{"year":2026,"finding":"BOK interacts with and increases UMPS enzymatic activity to promote UMP synthesis. BOK deficiency increases baseline DNA damage and p53 activation. In p53-deficient NSCLC cells, BOK loss elevates DNA damage and increases dependence on ATR-mediated repair, creating a synthetic lethal interaction with the ATR inhibitor ceralasertib. The DNA damage in BOK-deficient cells was rescued by a cell-permeable BOK-BH3-derived peptide, linking BOK's effect on genomic stability to its UMPS-regulatory function.","method":"UMPS activity assay, Bok-deficient NSCLC cell lines, ATR inhibitor (ceralasertib) treatment, DNA damage markers, BOK-BH3 peptide rescue, p53-deficient cell models","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — enzymatic assay plus peptide rescue plus synthetic lethality in multiple cell models, single lab","pmids":["41611842"],"is_preprint":false},{"year":2026,"finding":"EGR3 is a transcription factor that directly binds to the BOK gene promoter to transcriptionally activate BOK expression, as demonstrated by ChIP and dual luciferase reporter assays. BOK promotes mitochondrial apoptosis in response to arsenic exposure downstream of EGR3.","method":"ChIP, dual luciferase reporter assay, EGR3/BOK overexpression/knockdown, apoptosis assay","journal":"Phytomedicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assay identifies direct transcriptional regulation, single lab","pmids":["42097002"],"is_preprint":false}],"current_model":"BOK is a BCL-2 family effector protein that primarily localizes to the ER and Golgi membranes via a C-terminal tail-anchor, where it constitutively binds IP3Rs (preferentially IP3R1/2) at a defined coupling-domain site to suppress IP3R-mediated Ca2+ release—a function reversed by PKA-mediated Ser-8 phosphorylation; BOK promotes ER-mitochondria contact site proximity and calcium transfer required for ER stress-induced apoptosis, regulates mitochondrial fusion/morphology and bioenergetics, and enhances UMPS activity to support uridine biosynthesis and genomic stability; BOK protein stability is governed by AMFR/gp78-mediated ubiquitylation and VCP/p97-dependent proteasomal degradation (which is itself counteracted by IP3R binding), and BOK can act as a non-canonical, intrinsically metastable effector of MOMP independently of BAX and BAK when stabilized, with its pro-apoptotic activity regulated through both BH3-groove and transmembrane-domain interactions with anti-apoptotic partners (selectively Mcl-1, Bfl-1, BHRF1, and BCL-2 via TMD)."},"narrative":{"mechanistic_narrative":"BOK is a pro-apoptotic BCL-2 family effector that links endoplasmic reticulum/Golgi membrane biology to mitochondrial outer membrane permeabilization (MOMP) and intrinsic apoptosis [PMID:9356461, PMID:23429263, PMID:26949185]. It was originally defined by a BH1/BH2/BH3-domain architecture lacking BH4 and a selective heterodimerization pattern with anti-apoptotic Mcl-1, Bfl-1, and BHRF1 but not Bcl-2, Bcl-xL, or Bcl-w [PMID:9356461]. Endogenous BOK is tail-anchored at the ER and Golgi membranes [PMID:23429263], where it binds strongly and constitutively to inositol-1,4,5-trisphosphate receptors, preferring IP3R1/IP3R2, through a high-affinity site within the largely disordered IP3R1 coupling-domain loop (residues ~1898–1940) [PMID:23884412, PMID:33773141]. Through this interaction BOK suppresses IP3R-mediated Ca2+ release—an inhibition relieved by PKA-mediated Ser-8 phosphorylation that weakens BOK–IP3R1 binding [PMID:39810210]—and establishes ER–mitochondria proximity and the ER-to-mitochondria Ca2+ transfer required for ER-stress-induced apoptosis [PMID:33691099]. Consistent with this ER-centric role, Bok-deficient cells are selectively defective in apoptosis triggered by ER stressors and show an attenuated unfolded protein response and reduced chaperone availability [PMID:26015568, PMID:36060797]. BOK can act as a non-canonical MOMP effector that triggers cytochrome c release independently of BAX and BAK; its activity is metastability-driven rather than dependent on activator BH3 ligands, and a stabilizing helix-α1 glycine substitution inhibits permeabilization [PMID:26949185, PMID:29768206]. BOK is held at low abundance by AMFR/gp78-mediated ubiquitylation and VCP/p97-dependent proteasomal degradation, with IP3R binding stabilizing the protein, so that stabilization (by proteasome/VCP/gp78 impairment or loss of degradation machinery) permits BOK-driven apoptosis [PMID:26949185, PMID:36601536]. Beyond cell death, BOK promotes mitochondrial fusion and regulates mitochondrial morphology and bioenergetics [PMID:27098698, PMID:30976095], and it enhances uridine monophosphate synthetase (UMPS) activity to support uridine biosynthesis, chemosensitivity to 5-fluorouracil, and genomic stability [PMID:31311867, PMID:41611842]. Its pro-apoptotic activity is restrained by anti-apoptotic partners through both BH3-groove and transmembrane-domain interactions, the latter mediating selective inhibition by MCL-1 and by BCL-2 at the ER membrane [PMID:30127460, PMID:39048751].","teleology":[{"year":1997,"claim":"Established BOK as a distinct pro-apoptotic BCL-2 family member, defining its domain content and an unusual selective binding to a subset of anti-apoptotic proteins.","evidence":"Yeast two-hybrid screening and mammalian overexpression/rescue assays","pmids":["9356461"],"confidence":"High","gaps":["Did not address endogenous localization or physiological function","Heterodimerization specificity not mapped to structural determinants"]},{"year":1998,"claim":"Showed heterodimerization with anti-apoptotic proteins is dispensable for BOK killing, decoupling its pro-apoptotic activity from BH3-mediated binding.","evidence":"Splice-variant and BH3 mutagenesis with in vitro binding and cell-death assays","pmids":["9804769"],"confidence":"High","gaps":["Mechanism of killing independent of dimerization not defined","Endogenous relevance of the splice variant not established"]},{"year":2004,"claim":"Placed BOK in the p53-dependent DNA-damage apoptosis pathway upstream of cytochrome c release.","evidence":"p53 activation, protein-synthesis inhibition, and cytochrome c translocation assays in tumor cells","pmids":["15102863"],"confidence":"Medium","gaps":["No BOK knockout validation of the requirement","Direct vs indirect role in cytochrome c release unresolved"]},{"year":2006,"claim":"Identified transcriptional (E2F) and post-translational (Crm1-mediated nuclear export) controls on BOK abundance and localization.","evidence":"ChIP/luciferase promoter analysis and leptomycin B/Co-IP localization studies","pmids":["16772296","16302269"],"confidence":"Medium","gaps":["Functional consequence of nuclear BOK pool unclear","Cell-cycle coupling of BOK function not demonstrated"]},{"year":2013,"claim":"Defined BOK as a tail-anchored ER/Golgi membrane protein that constitutively binds IP3R1/2 at a discrete coupling-domain site and protects IP3Rs from proteolysis.","evidence":"Subcellular fractionation, microscopy, reciprocal Co-IP, domain mapping, and protease-protection assays","pmids":["23429263","23884412"],"confidence":"High","gaps":["Functional consequence of IP3R binding for Ca2+ signaling not yet measured","Relationship between membrane localization and MOMP activity unresolved"]},{"year":2013,"claim":"Demonstrated in vivo that BOK overlaps functionally with BAX (not BAK) in physiological apoptosis using compound knockout mice.","evidence":"Bok/Bax and Bok/Bak compound knockout mice with ovarian histology","pmids":["23744350"],"confidence":"Medium","gaps":["Molecular basis of BAX-overlap not defined","Tissue specificity of overlapping function not generalized"]},{"year":2015,"claim":"Established a selective, non-redundant requirement for BOK in ER-stress-induced apoptosis that BAX and BAK cannot compensate.","evidence":"Bok-/- MEFs challenged with multiple ER stressors plus UPR readouts and in vivo challenge","pmids":["26015568"],"confidence":"High","gaps":["Mechanistic link between ER localization and apoptotic execution not yet defined","Whether the effect requires IP3R binding untested at this stage"]},{"year":2016,"claim":"Defined BOK as a constitutively active, BAX/BAK-independent MOMP effector whose activity is governed primarily by gp78/VCP-dependent proteasomal degradation.","evidence":"BAX/BAK-DKO cells, ubiquitylation assays, gp78/VCP knockdown, and MOMP/apoptosis readouts","pmids":["26949185","27076518"],"confidence":"High","gaps":["Whether endogenous BOK acts this way under physiological conditions later contested","Structural basis of constitutive activity not resolved here"]},{"year":2016,"claim":"Revealed a non-apoptotic, MCL-1-dependent role for BOK in neuronal mitochondrial bioenergetics and calcium homeostasis under metabolic stress.","evidence":"Bok-/- neurons with calcium imaging, bioenergetics, MCL-1 rescue, and in vivo seizure/ischemia models","pmids":["27098698"],"confidence":"High","gaps":["Mechanism by which BOK maintains MCL-1 levels unclear","Connection between bioenergetic and apoptotic roles not unified"]},{"year":2017,"claim":"Mapped multiple layers of BOK abundance control: post-transcriptional repression by TRIM28 and miR-296-5p, ER-associated DNAJB12/gp78 turnover, and a MAL/MRTF-SRF transcriptional input.","evidence":"RNA pulldown/reporter assays, Co-IP of degradation complexes, and ChIP/reporter promoter analysis","pmids":["28536268","30471638","29156771","22185759"],"confidence":"Medium","gaps":["Relative contribution of each regulatory layer in vivo unknown","Integration of transcriptional and degradative control not defined"]},{"year":2017,"claim":"Tested BOK's intrinsic membrane-permeabilizing activity, showing it forms toroidal pores in liposomes but fails to permeabilize native BAX/BAK-null mitochondria.","evidence":"Recombinant BOKΔC liposome and isolated-mitochondria permeabilization assays with cBID/BCL-XL","pmids":["28064468"],"confidence":"Medium","gaps":["Additional factors required for mitochondrial activity unidentified","Negative mitochondrial result leaves native mechanism unresolved"]},{"year":2018,"claim":"Provided a structural basis for BOK activation as a metastability-driven process distinct from BH3-ligand-driven BAX/BAK activation.","evidence":"NMR structure of the BOK BCL-2 core, stability/denaturation assays, mutagenesis, and reconstituted MOMP","pmids":["29768206"],"confidence":"High","gaps":["Physiological trigger that exposes the metastable conformation unknown","Structure of full-length membrane-embedded BOK not determined"]},{"year":2018,"claim":"Confirmed structural similarity to BAX/BAK and demonstrated overlapping developmental cell-death function in triple-knockout mice.","evidence":"Structural comparison and Bok/Bax/Bak triple-knockout developmental phenotyping","pmids":["29775594"],"confidence":"High","gaps":["Tissue-level mechanism of the developmental requirement undefined","Quantitative contribution of BOK vs BAX/BAK not parsed"]},{"year":2018,"claim":"Localized inhibition of BOK by anti-apoptotic proteins to both BH3-groove and transmembrane-domain interactions, especially with MCL-1, and revealed BOK's role in CER-driven mitochondrial fission.","evidence":"Domain-deletion/mutagenesis apoptosis and interaction assays; gain/loss-of-function fission assays with DRP1/MFN2 readouts","pmids":["30127460","29463805"],"confidence":"Medium","gaps":["TMD interaction structure not resolved in these studies","Mechanistic link between BOK and DRP1/MFN2 regulation unclear"]},{"year":2019,"claim":"Uncovered two non-canonical BOK functions: positive regulation of UMPS-driven uridine biosynthesis/5-FU sensitivity and promotion of mitochondrial fusion.","evidence":"Bok-/- cells/mice with UMPS activity and 5-FU sensitivity assays; CRISPR-KO mitochondrial fusion-rate, bioenergetics, and rescue with IP3R-binding-deficient mutant","pmids":["31311867","30976095"],"confidence":"High","gaps":["Mechanism by which BOK enhances UMPS activity not defined","How fusion regulation relates to IP3R binding only partially separated"]},{"year":2020,"claim":"Showed transmembrane-domain heterooligomerization between MCL-1 and BOK occurs at mitochondria and modulates MAM contacts and BOK-dependent death.","evidence":"Split-GFP TMD interaction assay, localization analysis, MD simulation, and BOK-dependent death readouts","pmids":["33093207"],"confidence":"Medium","gaps":["Structural detail of TMD heterooligomers limited to simulation","Physiological stoichiometry of TMD complexes unknown"]},{"year":2021,"claim":"Demonstrated that the BOK–IP3R interaction specifically governs ER-to-mitochondria Ca2+ transfer and MAM composition required for ER-stress apoptosis, separable from mere organelle proximity.","evidence":"Bok-/- MEFs, proximity ligation, inducible ER-mitochondria linkers, IP3R-binding mutant rescue, and MAM proteomics","pmids":["33691099"],"confidence":"High","gaps":["Identity of MAM proteins functionally dependent on BOK not fully resolved","How Ca2+ transfer couples to MOMP execution undefined"]},{"year":2021,"claim":"Refined the BOK proximal interactome, confirming proximity to fission (Drp1) and ER-PM (Stim1) machinery and a TMD-dependent physical interaction with MCL-1 distinct from BAK.","evidence":"TurboID proximity labeling/MS, Co-IP, and TMD-deletion mutants","pmids":["34136494"],"confidence":"Medium","gaps":["Functional consequence of most proximal partners untested","Endogenous vs overexpression interactome differences not parsed"]},{"year":2021,"claim":"Defined the BOK–IP3R1 binding interface at atomic detail, showing high-affinity multivalent binding to a disordered IP3R1 loop.","evidence":"Disorder prediction, in vitro pulldown with purified proteins/peptides, Kd measurement, and mutagenesis","pmids":["33773141"],"confidence":"High","gaps":["BOK surface mediating binding not co-mapped here","Whether binding alters IP3R channel gating not tested in this study"]},{"year":2022,"claim":"Established IP3R binding as the dominant determinant of endogenous BOK stability and challenged the model of endogenous BOK as a proteasome-controlled constitutive MOMP effector.","evidence":"IP3R-knockout cells, proteasome inhibition, ubiquitylation and stability assays, and TMD mutants","pmids":["36601536"],"confidence":"Medium","gaps":["Reconciliation with gp78/VCP degradation model incomplete","Context determining when endogenous BOK is apoptotically active unclear"]},{"year":2022,"claim":"Linked BOK to ER proteostasis by showing it sustains the unfolded protein response and chaperone availability.","evidence":"UPR reporter cells and FRAP of GRP78/BiP-eGFP in Bok-deficient cells/neurons","pmids":["36060797"],"confidence":"Medium","gaps":["Mechanism by which BOK modulates BiP/UPR not defined","Whether the effect requires IP3R binding untested"]},{"year":2022,"claim":"Identified BOK as a host target hijacked by SARS-CoV-2 M protein to drive BAX/BAK-independent apoptosis via inhibition of BOK ubiquitination.","evidence":"CRISPR-KO/rescue, Co-IP, ubiquitination and domain-deletion assays, and in vivo lentiviral model","pmids":["35022571"],"confidence":"High","gaps":["Generalizability beyond M protein to other viral contexts unknown","BH2-domain interaction interface not structurally resolved"]},{"year":2025,"claim":"Demonstrated direct functional suppression of IP3R1-mediated Ca2+ mobilization by BOK and identified PKA Ser-8 phosphorylation as a switch reversing this suppression.","evidence":"Ca2+ sensor assays with GPCR stimulation, in vitro PKA phosphorylation of purified proteins, MS, and phosphomimetic mutagenesis","pmids":["39810210"],"confidence":"High","gaps":["Upstream signals controlling PKA-dependent BOK phosphorylation unknown","Physiological settings where this switch operates undefined"]},{"year":2024,"claim":"Resolved a TMD-mediated mechanism by which anti-apoptotic BCL-2 inhibits BOK at the ER membrane.","evidence":"Split-luciferase TMD interaction in cells, MD simulation of heterotetramers, BCL-2-TMD mutagenesis, and apoptosis assays","pmids":["39048751"],"confidence":"High","gaps":["Structural model rests on simulation rather than experimental structure","Relative contribution of TMD vs BH3-groove inhibition in cells not quantified"]},{"year":2026,"claim":"Connected BOK's UMPS-regulatory activity to genomic stability, creating an ATR-inhibitor synthetic lethality in p53-deficient cancer cells, and identified additional transcriptional and protein-stability regulators.","evidence":"UMPS activity assays, Bok-deficient NSCLC cells with ATR inhibitor, BOK-BH3 peptide rescue, and EGR3 ChIP/reporter analysis","pmids":["41611842","42097002"],"confidence":"Medium","gaps":["Molecular basis of BOK-UMPS activation still undefined","Direct mechanism linking UMP synthesis to DNA-damage prevention incomplete"]},{"year":null,"claim":"How BOK integrates its ER/IP3R-bound Ca2+-regulatory role, its metastable MOMP-effector activity, and its non-apoptotic metabolic and mitochondrial-dynamics functions into a single physiological program remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of full-length, membrane-embedded or IP3R-bound BOK","The physiological trigger that converts stable ER-resident BOK into an active MOMP effector is unknown","Whether the UMPS/uridine and apoptotic functions are mechanistically linked is undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[6,22,29]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[19,33]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[9,12,15]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[5,6,8,22,27]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[5]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[9,11,20,21,25]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,9,16]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[8,26]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[19,33]}],"complexes":[],"partners":["ITPR1","ITPR2","MCL1","BCL2","AMFR","VCP","DNAJB12","UMPS"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UMX3","full_name":"Bcl-2-related ovarian killer protein","aliases":["Bcl-2-like protein 9","Bcl2-L-9"],"length_aa":212,"mass_kda":23.3,"function":"Apoptosis regulator that functions through different apoptotic signaling pathways (PubMed:15102863, PubMed:20673843, PubMed:27076518). Plays a roles as pro-apoptotic protein that positively regulates intrinsic apoptotic process in a BAX- and BAK1-dependent manner or in a BAX- and BAK1-independent manner (PubMed:15102863, PubMed:27076518). In response to endoplasmic reticulum stress promotes mitochondrial apoptosis through downstream BAX/BAK1 activation and positive regulation of PERK-mediated unfolded protein response (By similarity). Activates apoptosis independently of heterodimerization with survival-promoting BCL2 and BCL2L1 through induction of mitochondrial outer membrane permeabilization, in a BAX- and BAK1-independent manner, in response to inhibition of ERAD-proteasome degradation system, resulting in cytochrome c release (PubMed:27076518). In response to DNA damage, mediates intrinsic apoptotic process in a TP53-dependent manner (PubMed:15102863). Plays a role in granulosa cell apoptosis by CASP3 activation (PubMed:20673843). Plays a roles as anti-apoptotic protein during neuronal apoptotic process, by negatively regulating poly ADP-ribose polymerase-dependent cell death through regulation of neuronal calcium homeostasis and mitochondrial bioenergetics in response to NMDA excitation (By similarity). In addition to its role in apoptosis, may regulate trophoblast cell proliferation during the early stages of placental development, by acting on G1/S transition through regulation of CCNE1 expression (PubMed:19942931). May also play a role as an inducer of autophagy by disrupting interaction between MCL1 and BECN1 (PubMed:24113155) Pro-apoptotic molecule exerting its function through the mitochondrial pathway","subcellular_location":"Membrane; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9UMX3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BOK","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BOK","total_profiled":1310},"omim":[{"mim_id":"621527","title":"TRANSMEMBRANE PROTEIN 145; TMEM145","url":"https://www.omim.org/entry/621527"},{"mim_id":"620560","title":"CEBPA DIVERGENT TRANSCRIPT; CEBPA-DT","url":"https://www.omim.org/entry/620560"},{"mim_id":"619847","title":"NEURODEGENERATION, CHILDHOOD-ONSET, WITH PROGRESSIVE MICROCEPHALY; CONPM","url":"https://www.omim.org/entry/619847"},{"mim_id":"618004","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 64; DEE64","url":"https://www.omim.org/entry/618004"},{"mim_id":"617768","title":"KLEEFSTRA SYNDROME 2; KLEFS2","url":"https://www.omim.org/entry/617768"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":116.2},{"tissue":"liver","ntpm":95.9}],"url":"https://www.proteinatlas.org/search/BOK"},"hgnc":{"alias_symbol":["BCL2L9","BOKL","MGC4631"],"prev_symbol":[]},"alphafold":{"accession":"Q9UMX3","domains":[{"cath_id":"1.10.437.10","chopping":"24-185","consensus_level":"medium","plddt":87.838,"start":24,"end":185}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UMX3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UMX3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UMX3-F1-predicted_aligned_error_v6.png","plddt_mean":83.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BOK","jax_strain_url":"https://www.jax.org/strain/search?query=BOK"},"sequence":{"accession":"Q9UMX3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UMX3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UMX3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UMX3"}},"corpus_meta":[{"pmid":"9356461","id":"PMC_9356461","title":"Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9356461","citation_count":285,"is_preprint":false},{"pmid":"26949185","id":"PMC_26949185","title":"BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26949185","citation_count":223,"is_preprint":false},{"pmid":"29775594","id":"PMC_29775594","title":"Embryogenesis and Adult Life in the Absence of Intrinsic Apoptosis Effectors BAX, BAK, and BOK.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/29775594","citation_count":171,"is_preprint":false},{"pmid":"31570337","id":"PMC_31570337","title":"BAX, BAK, and BOK: A Coming of Age for the BCL-2 Family Effector Proteins.","date":"2020","source":"Cold Spring Harbor perspectives in biology","url":"https://pubmed.ncbi.nlm.nih.gov/31570337","citation_count":146,"is_preprint":false},{"pmid":"15102863","id":"PMC_15102863","title":"BOK and NOXA are essential mediators of p53-dependent apoptosis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15102863","citation_count":123,"is_preprint":false},{"pmid":"28315370","id":"PMC_28315370","title":"Control of mitochondrial physiology and cell death by the Bcl-2 family proteins Bax and Bok.","date":"2017","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/28315370","citation_count":117,"is_preprint":false},{"pmid":"26015568","id":"PMC_26015568","title":"BCL-2 family member BOK promotes apoptosis in response to endoplasmic reticulum stress.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26015568","citation_count":113,"is_preprint":false},{"pmid":"23429263","id":"PMC_23429263","title":"Intracellular localization of the BCL-2 family member BOK and functional implications.","date":"2013","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/23429263","citation_count":111,"is_preprint":false},{"pmid":"22281706","id":"PMC_22281706","title":"BCL-2 family member BOK is widely expressed but its loss has only minimal impact in mice.","date":"2012","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/22281706","citation_count":96,"is_preprint":false},{"pmid":"29463805","id":"PMC_29463805","title":"Ceramide-induced BOK promotes mitochondrial fission in preeclampsia.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29463805","citation_count":92,"is_preprint":false},{"pmid":"23884412","id":"PMC_23884412","title":"The Bcl-2 protein family member Bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23884412","citation_count":87,"is_preprint":false},{"pmid":"35022571","id":"PMC_35022571","title":"SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK.","date":"2022","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/35022571","citation_count":82,"is_preprint":false},{"pmid":"33691099","id":"PMC_33691099","title":"BOK controls apoptosis by Ca2+ transfer through ER-mitochondrial contact sites.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33691099","citation_count":68,"is_preprint":false},{"pmid":"23744350","id":"PMC_23744350","title":"Consequences of the combined loss of BOK and BAK or BOK and BAX.","date":"2013","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/23744350","citation_count":59,"is_preprint":false},{"pmid":"30976095","id":"PMC_30976095","title":"Bok regulates mitochondrial fusion and morphology.","date":"2019","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/30976095","citation_count":58,"is_preprint":false},{"pmid":"25419600","id":"PMC_25419600","title":"Anthocyanin accumulation and transcriptional regulation of anthocyanin biosynthesis in purple bok choy (Brassica rapa var. chinensis).","date":"2014","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25419600","citation_count":57,"is_preprint":false},{"pmid":"24113155","id":"PMC_24113155","title":"Placental autophagy regulation by the BOK-MCL1 rheostat.","date":"2013","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/24113155","citation_count":54,"is_preprint":false},{"pmid":"29768206","id":"PMC_29768206","title":"Intrinsic Instability of BOK Enables Membrane Permeabilization in Apoptosis.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29768206","citation_count":50,"is_preprint":false},{"pmid":"27098698","id":"PMC_27098698","title":"Bok Is Not Pro-Apoptotic But Suppresses Poly ADP-Ribose Polymerase-Dependent Cell Death Pathways and Protects against Excitotoxic and Seizure-Induced Neuronal Injury.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27098698","citation_count":49,"is_preprint":false},{"pmid":"19287972","id":"PMC_19287972","title":"A natural antisense transcript, BOKAS, regulates the pro-apoptotic activity of human Bok.","date":"2009","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19287972","citation_count":49,"is_preprint":false},{"pmid":"31324752","id":"PMC_31324752","title":"Raptinal bypasses BAX, BAK, and BOK for mitochondrial outer membrane permeabilization and intrinsic apoptosis.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31324752","citation_count":46,"is_preprint":false},{"pmid":"9804769","id":"PMC_9804769","title":"A splicing variant of the Bcl-2 member Bok with a truncated BH3 domain induces apoptosis but does not dimerize with antiapoptotic Bcl-2 proteins in vitro.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9804769","citation_count":46,"is_preprint":false},{"pmid":"33043006","id":"PMC_33043006","title":"The Multifaceted Roles of the BCL-2 Family Member BOK.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33043006","citation_count":44,"is_preprint":false},{"pmid":"16772296","id":"PMC_16772296","title":"Bok, Bcl-2-related Ovarian Killer, Is Cell Cycle-regulated and Sensitizes to Stress-induced Apoptosis.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16772296","citation_count":41,"is_preprint":false},{"pmid":"28064468","id":"PMC_28064468","title":"The membrane activity of BOK involves formation of large, stable toroidal pores and is promoted by cBID.","date":"2017","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/28064468","citation_count":41,"is_preprint":false},{"pmid":"28536268","id":"PMC_28536268","title":"Endoplasmic reticulum stress-induced degradation of DNAJB12 stimulates BOK accumulation and primes cancer cells for apoptosis.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28536268","citation_count":41,"is_preprint":false},{"pmid":"19942931","id":"PMC_19942931","title":"Mtd/Bok takes a swing: proapoptotic Mtd/Bok regulates trophoblast cell proliferation during human placental development and in preeclampsia.","date":"2009","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19942931","citation_count":39,"is_preprint":false},{"pmid":"35758142","id":"PMC_35758142","title":"The BCL-2 family member BID plays a role during embryonic development in addition to its BH3-only protein function by acting in parallel to BAX, BAK and BOK.","date":"2022","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/35758142","citation_count":38,"is_preprint":false},{"pmid":"27076518","id":"PMC_27076518","title":"Bok is a genuine multi-BH-domain protein that triggers apoptosis in the absence of Bax and Bak.","date":"2016","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/27076518","citation_count":38,"is_preprint":false},{"pmid":"33093207","id":"PMC_33093207","title":"Mcl-1 and Bok transmembrane domains: Unexpected players in the modulation of apoptosis.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33093207","citation_count":37,"is_preprint":false},{"pmid":"31311867","id":"PMC_31311867","title":"BCL-2 family protein BOK is a positive regulator of uridine metabolism in mammals.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31311867","citation_count":34,"is_preprint":false},{"pmid":"26492371","id":"PMC_26492371","title":"Impact of the combined loss of BOK, BAX and BAK on the hematopoietic system is slightly more severe than compound loss of BAX and BAK.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/26492371","citation_count":34,"is_preprint":false},{"pmid":"16302269","id":"PMC_16302269","title":"Nuclear translocation of the pro-apoptotic Bcl-2 family member Bok induces apoptosis.","date":"2006","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/16302269","citation_count":33,"is_preprint":false},{"pmid":"29229991","id":"PMC_29229991","title":"BOK promotes chemical-induced hepatocarcinogenesis in mice.","date":"2017","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/29229991","citation_count":30,"is_preprint":false},{"pmid":"28744854","id":"PMC_28744854","title":"BOK displays cell death-independent tumor suppressor activity in non-small-cell lung carcinoma.","date":"2017","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28744854","citation_count":28,"is_preprint":false},{"pmid":"29635130","id":"PMC_29635130","title":"Avicularin reversed multidrug-resistance in human gastric cancer through enhancing Bax and BOK expressions.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/29635130","citation_count":26,"is_preprint":false},{"pmid":"21184732","id":"PMC_21184732","title":"WNT signaling controls expression of pro-apoptotic BOK and BAX in intestinal cancer.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21184732","citation_count":25,"is_preprint":false},{"pmid":"20673843","id":"PMC_20673843","title":"Regulation of cell death in human fetal and adult ovaries--role of Bok and Bcl-X(L).","date":"2010","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20673843","citation_count":24,"is_preprint":false},{"pmid":"31201960","id":"PMC_31201960","title":"Effects of bok choy on the dissipation of dibutyl phthalate (DBP) in mollisol and its possible mechanisms of biochemistry and microorganisms.","date":"2019","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/31201960","citation_count":24,"is_preprint":false},{"pmid":"35180317","id":"PMC_35180317","title":"Modeling apoptosis resistance in CHO cells with CRISPR-mediated knockouts of Bak1, Bax, and Bok.","date":"2022","source":"Biotechnology and bioengineering","url":"https://pubmed.ncbi.nlm.nih.gov/35180317","citation_count":23,"is_preprint":false},{"pmid":"33291826","id":"PMC_33291826","title":"The Mysteries around the BCL-2 Family Member BOK.","date":"2020","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33291826","citation_count":21,"is_preprint":false},{"pmid":"33580830","id":"PMC_33580830","title":"Development of a nanobody-based ELISA for the detection of the insecticides cyantraniliprole and chlorantraniliprole in soil and the vegetable bok choy.","date":"2021","source":"Analytical and bioanalytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33580830","citation_count":21,"is_preprint":false},{"pmid":"16824579","id":"PMC_16824579","title":"Effects of endocrine disruptor di-n-butyl phthalate on the growth of Bok choy (Brassica rapa subsp. chinensis).","date":"2006","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/16824579","citation_count":21,"is_preprint":false},{"pmid":"34001648","id":"PMC_34001648","title":"CEBPA-AS1 Knockdown Alleviates Oxygen-Glucose Deprivation/Reperfusion-Induced Neuron Cell Damage by the MicroRNA 24-3p/BOK Axis.","date":"2021","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/34001648","citation_count":20,"is_preprint":false},{"pmid":"11720903","id":"PMC_11720903","title":"The expression and regulation of Bcl-2-related ovarian killer (Bok) mRNA in the developing and adult rat testis.","date":"2001","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11720903","citation_count":20,"is_preprint":false},{"pmid":"29156771","id":"PMC_29156771","title":"Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive or die.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29156771","citation_count":20,"is_preprint":false},{"pmid":"22185759","id":"PMC_22185759","title":"Myocardin-related transcription factor A regulates expression of Bok and Noxa and is involved in apoptotic signalling.","date":"2012","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/22185759","citation_count":18,"is_preprint":false},{"pmid":"41365932","id":"PMC_41365932","title":"Allelopathic effects of tree peony extracts on bok choy, spinach and tatsoi.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41365932","citation_count":16,"is_preprint":false},{"pmid":"30127460","id":"PMC_30127460","title":"Contribution of BH3-domain and Transmembrane-domain to the Activity and Interaction of the Pore-forming Bcl-2 Proteins Bok, Bak, and Bax.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30127460","citation_count":16,"is_preprint":false},{"pmid":"29879573","id":"PMC_29879573","title":"How do root exudates of bok choy promote dibutyl phthalate adsorption on mollisol?","date":"2018","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/29879573","citation_count":15,"is_preprint":false},{"pmid":"39048751","id":"PMC_39048751","title":"BCL-2 and BOK regulate apoptosis by interaction of their C-terminal transmembrane domains.","date":"2024","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/39048751","citation_count":14,"is_preprint":false},{"pmid":"34136494","id":"PMC_34136494","title":"Identification of the Bok Interactome Using Proximity Labeling.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34136494","citation_count":13,"is_preprint":false},{"pmid":"37123400","id":"PMC_37123400","title":"Bok: real killer or bystander with non-apoptotic roles?","date":"2023","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/37123400","citation_count":12,"is_preprint":false},{"pmid":"27156889","id":"PMC_27156889","title":"BOK: Oddball of the BCL-2 Family.","date":"2016","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27156889","citation_count":12,"is_preprint":false},{"pmid":"35091677","id":"PMC_35091677","title":"The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35091677","citation_count":11,"is_preprint":false},{"pmid":"31323016","id":"PMC_31323016","title":"Role of B-Cell Lymphoma 2 Ovarian Killer (BOK) in Acute Toxicity of Human Lung Epithelial Cells Caused by Cadmium Chloride.","date":"2019","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/31323016","citation_count":10,"is_preprint":false},{"pmid":"30471638","id":"PMC_30471638","title":"Negative Regulation of BOK Expression by Recruitment of TRIM28 to Regulatory Elements in Its 3' Untranslated Region.","date":"2018","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/30471638","citation_count":10,"is_preprint":false},{"pmid":"25982403","id":"PMC_25982403","title":"Molecular profiles and pathogen-induced transcriptional responses of prawn B cell lymphoma-2 related ovarian killer protein (BOK).","date":"2015","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25982403","citation_count":10,"is_preprint":false},{"pmid":"11804337","id":"PMC_11804337","title":"The expression of Bok is regulated by serum in HC11 mammary epithelial cells.","date":"2001","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/11804337","citation_count":10,"is_preprint":false},{"pmid":"24806027","id":"PMC_24806027","title":"Hypoxia-inducible regulation of placental BOK expression.","date":"2014","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24806027","citation_count":9,"is_preprint":false},{"pmid":"36060797","id":"PMC_36060797","title":"BOK controls ER proteostasis and physiological ER stress responses in neurons.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/36060797","citation_count":8,"is_preprint":false},{"pmid":"36601536","id":"PMC_36601536","title":"Endogenous Bok is stable at the endoplasmic reticulum membrane and does not mediate proteasome inhibitor-induced apoptosis.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/36601536","citation_count":8,"is_preprint":false},{"pmid":"15474552","id":"PMC_15474552","title":"Ge-Jee-Bok-Ryung-Hwan induces apoptosis in human cervical carcinoma HeLa cells--an endoplasmic reticulum stress pathway--.","date":"2004","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15474552","citation_count":8,"is_preprint":false},{"pmid":"33773141","id":"PMC_33773141","title":"Bok binds to a largely disordered loop in the coupling domain of type 1 inositol 1,4,5-trisphosphate receptor.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/33773141","citation_count":8,"is_preprint":false},{"pmid":"36599139","id":"PMC_36599139","title":"Necrostatin-1 prevents skeletal muscle ischemia reperfusion injury by regulating Bok-mediated apoptosis.","date":"2023","source":"Journal of the Chinese Medical Association : JCMA","url":"https://pubmed.ncbi.nlm.nih.gov/36599139","citation_count":7,"is_preprint":false},{"pmid":"31203423","id":"PMC_31203423","title":"BOK promotes erythropoiesis in a mouse model of myelodysplastic syndrome.","date":"2019","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/31203423","citation_count":7,"is_preprint":false},{"pmid":"15177115","id":"PMC_15177115","title":"Role of Mtd/Bok in normal and neoplastic B-cell development in the bursa of Fabricius.","date":"2004","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15177115","citation_count":6,"is_preprint":false},{"pmid":"36989987","id":"PMC_36989987","title":"Assessment of CuO NPs on soil microbial community structure based on phospholipid fatty acid techniques and phytotoxicity of bok choy seedlings.","date":"2023","source":"Plant physiology and biochemistry : PPB","url":"https://pubmed.ncbi.nlm.nih.gov/36989987","citation_count":6,"is_preprint":false},{"pmid":"28262002","id":"PMC_28262002","title":"There is something about BOK we just don't get yet.","date":"2017","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/28262002","citation_count":6,"is_preprint":false},{"pmid":"40588154","id":"PMC_40588154","title":"Root and foliar uptake, bidirectional translocation, subcellular distribution, and metabolism of tire wear particle-derived p-phenylenediamines and their quinones in Chinese cabbage and bok choy.","date":"2025","source":"Environmental pollution (Barking, Essex : 1987)","url":"https://pubmed.ncbi.nlm.nih.gov/40588154","citation_count":5,"is_preprint":false},{"pmid":"26994672","id":"PMC_26994672","title":"Identification of the Bcl-2 family protein gene BOK from orange-spotted grouper (Epinephelus coioides) involved in SGIV infection.","date":"2016","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26994672","citation_count":4,"is_preprint":false},{"pmid":"27269726","id":"PMC_27269726","title":"Cell Biology: ERADicating Survival with BOK.","date":"2016","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/27269726","citation_count":4,"is_preprint":false},{"pmid":"39376241","id":"PMC_39376241","title":"Non-thermal plasma enhances growth and salinity tolerance of bok choy (Brassica rapa subsp. chinensis) in hydroponic culture.","date":"2024","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/39376241","citation_count":3,"is_preprint":false},{"pmid":"39850370","id":"PMC_39850370","title":"BcWRKY25-BcWRKY33A-BcLRP1/BcCOW1 module promotes root development for improved salt tolerance in Bok choy.","date":"2024","source":"Horticulture research","url":"https://pubmed.ncbi.nlm.nih.gov/39850370","citation_count":3,"is_preprint":false},{"pmid":"33553610","id":"PMC_33553610","title":"BOK-MCL1 transmembrane interactions: a challenging target for cancer therapy.","date":"2021","source":"Molecular & cellular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33553610","citation_count":3,"is_preprint":false},{"pmid":"38674501","id":"PMC_38674501","title":"Physiological and Transcriptomic Responses of Bok Choy to Heat Stress.","date":"2024","source":"Plants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/38674501","citation_count":2,"is_preprint":false},{"pmid":"33807047","id":"PMC_33807047","title":"Loss of BOK Has a Minor Impact on Acetaminophen Overdose-Induced Liver Damage in Mice.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33807047","citation_count":2,"is_preprint":false},{"pmid":"37364417","id":"PMC_37364417","title":"Up-regulation of BOK-AS1, FAM215A and FEZF1-AS1 lncRNAs and their potency as moderate diagnostic biomarkers in gastric cancer.","date":"2023","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/37364417","citation_count":1,"is_preprint":false},{"pmid":"39395501","id":"PMC_39395501","title":"Interactive effects of microplastics and cadmium on soil properties, microbial communities and bok choy growth.","date":"2024","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/39395501","citation_count":1,"is_preprint":false},{"pmid":"39996719","id":"PMC_39996719","title":"BCL-B Promotes Lung Cancer Invasiveness by Direct Inhibition of BOK.","date":"2025","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/39996719","citation_count":1,"is_preprint":false},{"pmid":"41611842","id":"PMC_41611842","title":"Loss of BOK increases vulnerability of p53 deficient non-small cell lung cancer cells to ATR inhibition through its role in uridine metabolism.","date":"2026","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/41611842","citation_count":1,"is_preprint":false},{"pmid":"39810210","id":"PMC_39810210","title":"Phosphorylation of Bok at Ser-8 blocks its ability to suppress IP3R-mediated calcium mobilization.","date":"2025","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/39810210","citation_count":0,"is_preprint":false},{"pmid":"40806384","id":"PMC_40806384","title":"Low BOK Expression Promotes Epithelial-Mesenchymal Transition and Migration via the Wnt Signaling Pathway in Breast Cancer Cells.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40806384","citation_count":0,"is_preprint":false},{"pmid":"37888203","id":"PMC_37888203","title":"Discovery and Comprehensive Characterization of Novel Circular RNAs of the Apoptosis-Related BOK Gene in Human Ovarian and Prostate Cancer Cells, Using Nanopore Sequencing.","date":"2023","source":"Non-coding RNA","url":"https://pubmed.ncbi.nlm.nih.gov/37888203","citation_count":0,"is_preprint":false},{"pmid":"41608624","id":"PMC_41608624","title":"Gastrodin alleviates high fructose-induced podocyte mitochondria-mediated apoptosis by inhibiting NLRP6 to facilitate TRIM7-triggered Bok mRNA degradation.","date":"2026","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41608624","citation_count":0,"is_preprint":false},{"pmid":"41754355","id":"PMC_41754355","title":"Molecular Hydrogen Improves Storage Quality of Bok Choy by Reducing Water Loss and Maintaining Cell Wall Integrity.","date":"2026","source":"Plants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/41754355","citation_count":0,"is_preprint":false},{"pmid":"41962374","id":"PMC_41962374","title":"Dynamics and drivers of last-resort antibiotic resistance genes during pilot-scale aerobic fermentation of municipal sludge and subsequent bok choy pot trials.","date":"2026","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/41962374","citation_count":0,"is_preprint":false},{"pmid":"42097002","id":"PMC_42097002","title":"Vitamin K2 (MK7) alleviates arsenic-induced cardiac hypertrophy by suppressing the EGR3/BOK mitochondrial apoptosis pathway.","date":"2026","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/42097002","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":42741,"output_tokens":9819,"usd":0.137754,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20246,"output_tokens":7120,"usd":0.139615,"stage2_stop_reason":"end_turn"},"total_usd":0.277369,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"BOK (Bcl-2-related ovarian killer) was identified as a pro-apoptotic BCL-2 family member containing BH1, BH2, and BH3 domains and a C-terminal transmembrane region but lacking the BH4 domain. In yeast two-hybrid assays, BOK interacted selectively with Mcl-1, BHRF1, and Bfl-1, but not with Bcl-2, Bcl-xL, or Bcl-w—a heterodimerization pattern distinct from other pro-apoptotic members (Bax, Bak, Bik). Overexpression of BOK in mammalian cells induced apoptosis that was blocked by P35 and suppressed by co-expression of Mcl-1 or BHRF1 but not Bcl-2.\",\n      \"method\": \"Yeast two-hybrid, mammalian cell overexpression, co-expression rescue assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal yeast two-hybrid plus functional mammalian cell rescue, foundational paper replicated by multiple subsequent studies\",\n      \"pmids\": [\"9356461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"A naturally occurring splicing variant of BOK (Bok-S) with a 43-residue deletion fusing the N-terminal half of BH3 to the C-terminal half of BH1 retained apoptosis-inducing activity but lost the ability to dimerize with anti-apoptotic proteins in vitro. Additional BH3 domain mutations in Bok-L also abolished heterodimerization without impairing pro-apoptotic function, indicating that heterodimerization with anti-apoptotic proteins is not required for BOK-mediated cell killing.\",\n      \"method\": \"Site-directed mutagenesis, in vitro binding assay, mammalian cell overexpression/apoptosis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro binding assay combined with mutagenesis and cell-death assays in a single focused study\",\n      \"pmids\": [\"9804769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In human neuroblastoma and breast cancer cells, DNA damage-induced apoptosis required new protein synthesis, p53 accumulation, and p53-dependent induction of BOK and NOXA genes, with cytochrome c translocation not dependent on BAX. This placed BOK downstream of p53 and upstream of cytochrome c release in the DNA-damage intrinsic apoptosis pathway.\",\n      \"method\": \"Protein synthesis inhibition, p53 activation assays, cytochrome c translocation assay, gene expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, pathway placement by inhibitor and expression analysis without direct BOK KO validation\",\n      \"pmids\": [\"15102863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BOK expression is cell cycle-regulated: Bok RNA is low in quiescent cells and rises upon serum stimulation. The mouse Bok promoter contains a conserved E2F binding site (−43 to −49); serum-dependent activation requires this site, and endogenous E2F1 and E2F3 associate with the Bok promoter in vivo by chromatin immunoprecipitation.\",\n      \"method\": \"RT-PCR, luciferase reporter assay, chromatin immunoprecipitation (ChIP), promoter cloning\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus luciferase reporter with site-specific mutation, single lab\",\n      \"pmids\": [\"16772296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Human BOK contains a leucine-rich nuclear export signal (NES) within its BH3 domain. BOK is present in both nucleus and cytoplasm; treatment with leptomycin B (Crm1 inhibitor) increases nuclear BOK. Crm1 co-immunoprecipitates wild-type BOK but not a NES-mutant BOK. Mutation of the NES increases nuclear localization and apoptotic activity, indicating that nuclear export of BOK is a regulated process mediated by Crm1.\",\n      \"method\": \"Western blot fractionation, leptomycin B treatment, site-directed mutagenesis, co-immunoprecipitation, immunocytochemistry\",\n      \"journal\": \"Molecular carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus mutagenesis plus localization, single lab\",\n      \"pmids\": [\"16302269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Endogenous BOK localizes predominantly to the membranes of the Golgi apparatus and ER (and associated membranes) via a C-terminal tail-anchor transmembrane domain. Overexpression of full-length BOK causes early fragmentation of ER and Golgi compartments. BOK-deficient cells showed abnormal responses to the Golgi/ER stressor brefeldin A. Enforced BOK expression in BAX/BAK-proficient cells activates the intrinsic apoptotic pathway, but BOK fails to kill cells lacking both BAX and BAK.\",\n      \"method\": \"Subcellular fractionation, immunofluorescence/confocal microscopy, BOK truncation constructs, Bok-/- MEFs, apoptosis assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal localization methods plus functional rescue experiments, replicated in subsequent studies\",\n      \"pmids\": [\"23429263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BOK binds strongly and constitutively to inositol 1,4,5-trisphosphate receptors (IP3Rs) in cells. BOK preferentially binds IP3R1 and IP3R2 but barely IP3R3. The binding site maps to a small region within the IP3R coupling domain (amino acids 1895–1903 of IP3R1). Essentially all cellular BOK is IP3R-bound in cells expressing substantial IP3Rs. BOK protects IP3Rs from proteolytic cleavage (by chymotrypsin in vitro and by caspase-3 in vivo) and regulates IP3R expression levels. Persistent IP3-dependent signaling triggers co-degradation of BOK and IP3R via the ubiquitin-proteasome pathway.\",\n      \"method\": \"Co-immunoprecipitation, in vitro pulldown, chymotrypsin protection assay, caspase-3 cleavage assay in apoptotic cells, IP3R truncation mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, domain mapping, in vitro protease protection assay, in vivo caspase-3 cleavage assay, multiple orthogonal methods in one study\",\n      \"pmids\": [\"23884412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Loss of BOK combined with loss of BAX in Bok-/-Bax-/- female mice resulted in abnormally increased numbers of oocytes from different developmental stages in aged animals, indicating an overlapping pro-apoptotic function of BOK and BAX in age-related follicular atresia. Combined loss of BOK and BAK showed no noticeable phenotypic defects.\",\n      \"method\": \"Genetic knockout mouse model, histological analysis of ovaries\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined phenotypic readout in compound knockout mouse, single lab\",\n      \"pmids\": [\"23744350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Bok-/- cells are selectively defective in apoptotic responses to ER stress stimuli (thapsigargin, A23187, brefeldin A, DTT, geldanamycin, bortezomib) but not to other apoptotic stimuli (etoposide, staurosporine, UV). BOK's predominant subcellular localization at the ER is consistent with this selective role. BAX and BAK cannot compensate for this ER stress apoptosis defect in BOK-deficient cells. Bok-/- cells also show diminished ATF4 and CHOP activation after ER stress.\",\n      \"method\": \"Bok-/- mouse embryonic fibroblasts, multiple ER stressor treatments, apoptosis assays, unfolded protein response (UPR) activation analysis, in vivo thapsigargin challenge\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined phenotypic readout, multiple stimuli, in vivo validation, replicated across cell types\",\n      \"pmids\": [\"26015568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BOK is a bona fide effector of mitochondrial outer membrane permeabilization (MOMP) that can trigger apoptosis in the absence of both BAX and BAK. Unlike BAX/BAK, BOK is constitutively active and unresponsive to antagonism by anti-apoptotic BCL-2 proteins. BOK is controlled at the level of protein stability: it is ubiquitylated by the AMFR/gp78 E3 ubiquitin ligase complex and targeted for proteasomal degradation in a VCP/p97-dependent manner. When proteasome function, VCP, or gp78 is compromised, BOK is stabilized and induces MOMP independently of other BCL-2 proteins.\",\n      \"method\": \"BAX/BAK double-knockout cells, proteasome inhibition, gp78/VCP knockdown, ubiquitylation assay, MOMP assay, apoptosis assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple cell systems, identification of E3 ubiquitin ligase and degradation machinery with functional validation, highly cited\",\n      \"pmids\": [\"26949185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BOK induces cytochrome c release and apoptosis independently of BAX and BAK in multiple cell systems. Endogenous BOK levels modulate apoptotic responses to chemotherapeutic drugs in ovarian carcinoma cells as shown by RNAi and targeted gene deletion of BOK.\",\n      \"method\": \"BAX/BAK-deficient cell systems, siRNA knockdown, CRISPR gene deletion, cytochrome c release assay, apoptosis assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal loss-of-function approaches (RNAi + CRISPR), multiple cell systems, single lab\",\n      \"pmids\": [\"27076518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In neurons, BOK is not required for staurosporine-, proteasome inhibition-, or excitotoxicity-induced apoptosis. Instead, BOK-deficient neurons are more sensitive to oxygen/glucose deprivation and seizure-induced injury. BOK deficiency reduces neuronal MCL-1 protein levels and causes disrupted mitochondrial bioenergetics and calcium homeostasis in response to excitotoxic stimuli, which could be rescued by MCL-1 overexpression. BOK-deficient neurons activate poly ADP-ribose polymerase-dependent cell death.\",\n      \"method\": \"Bok-/- neurons, single-cell calcium imaging, mitochondrial bioenergetics assay, MCL-1 overexpression rescue, in vivo seizure model, cell death pathway analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (imaging, bioenergetics, rescue) in both in vitro and in vivo neuronal models, single lab\",\n      \"pmids\": [\"27098698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Recombinant BOK (BOK∆C) permeabilizes liposomes mimicking mitochondrial outer membrane composition, forming large stable toroidal pores. Pore formation is enhanced by cBID and is refractory to BCL-XL. However, isolated mitochondria from Bax-/-Bak-/- cells were resistant to BOK-induced cytochrome c release even in the presence of cBID, suggesting that BOK's direct MOMP activity at native mitochondria requires additional factors or regulation.\",\n      \"method\": \"In vitro liposome permeabilization assay, isolated mitochondria cytochrome c release assay, recombinant protein, cBID/BCL-XL addition\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified proteins and liposomes, but mitochondrial result was negative/inconclusive, single lab\",\n      \"pmids\": [\"28064468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DNAJB12 (JB12), an ER-associated Hsp40 protein, is required to maintain BOK at low levels and is detected in complexes with JB12 and gp78. JB12 is degraded by ER-associated degradation complexes (containing HERP, Sel1L, gp78) during severe ER stress. JB12 knockdown leads to BOK accumulation and activation of Caspase 3, 7, and 9, sensitizing cells to proteotoxic agents.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, caspase activation assay, proteasome inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying complex, KD with defined apoptotic readout, single lab\",\n      \"pmids\": [\"28536268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Myocardin-related transcription factor MAL/MRTF-A directly induces Bok transcription via a CArG-like box in the Bok promoter in an SRF-dependent and actin-regulated manner. Chromatin immunoprecipitation confirms inducible recruitment of MAL and SRF to the Bok promoter. MAL-dependent Bok induction occurs downstream of TNF and staurosporin stimulation.\",\n      \"method\": \"Luciferase reporter assay, ChIP, actin drug (latrunculin) treatment, siRNA knockdown\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assay with site-specific elements, single lab\",\n      \"pmids\": [\"22185759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NMR structure of the BCL-2 core of human BOK reveals a conserved BCL-2 architecture with an atypical hydrophobic groove that undergoes conformational exchange. The BCL-2 core of BOK spontaneously associates with purified mitochondria and releases cytochrome c. Alanine substitution of a unique glycine in helix α1 stabilizes BOK and significantly inhibits MOMP, liposome permeabilization, and cell death. Activated BID does not activate WT BOK or the stabilized mutant, supporting a metastability-driven (rather than BH3 ligand-driven) mechanism of BOK activation.\",\n      \"method\": \"NMR structure determination, thermal shift assay, urea denaturation, in vitro MOMP assay with purified mitochondria, liposome permeabilization assay, alanine mutagenesis, cell death assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR structure plus reconstitution plus mutagenesis in one study, multiple orthogonal methods\",\n      \"pmids\": [\"29768206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BOK structural analysis reveals close resemblance to BAX and BAK. Triple-knockout (Bok-/-Bax-/-Bak-/-) mice exhibit more severe developmental defects and die earlier than Bax-/-Bak-/- mice, demonstrating that BOK has overlapping roles with BAX and BAK during developmental cell death in vivo.\",\n      \"method\": \"Structural analysis, triple-knockout mouse generation, developmental phenotype analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — triple-KO mouse with clear developmental phenotype establishing overlapping in vivo function, published in Cell\",\n      \"pmids\": [\"29775594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The ceramide (CER)/BOK axis promotes mitochondrial fission in preeclamptic placentae. BOK expression is increased by CER 16:0. Loss- and gain-of-function experiments showed BOK positively regulates phospho-DRP1/DRP1 and MFN2 expression and localizes mitochondrial fission events to ER/MAM compartments. The BH3 and transmembrane domains of BOK are required for this regulation of fission.\",\n      \"method\": \"Loss- and gain-of-function experiments, CER treatment, DRP1/MFN2 expression analysis, transmission electron microscopy, BOK domain deletion constructs\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mutagenesis plus gain/loss of function, defined phenotypic readout, single lab\",\n      \"pmids\": [\"29463805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The BH3 domain leucine-1 mutation (L70E) in BOK does not block apoptosis induction, but when combined with transmembrane domain deletion, the Bok(L70E)ΔTM double mutant shows enhanced pro-apoptotic activity by abolishing interaction with anti-apoptotic proteins, especially MCL-1. Deletion of the C-terminal transmembrane domain reduces pro-apoptotic function of BOK. The transmembrane domain thus contributes to BOK's interaction with and inhibition by MCL-1.\",\n      \"method\": \"Site-directed mutagenesis, domain deletion constructs, apoptosis assay, interaction analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis plus functional apoptosis and interaction assays, single lab\",\n      \"pmids\": [\"30127460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BOK is a positive regulator of uridine monophosphate synthetase (UMPS) activity. BOK expression enhances UMPS enzymatic activity, cell proliferation, and chemosensitivity to 5-fluorouracil (5-FU). Genetic deletion of Bok results in chemoresistance to 5-FU in cell lines and in vivo. Cancers resistant to 5-FU down-regulate BOK expression.\",\n      \"method\": \"Bok-/- cells and mice, UMPS activity assay, 5-FU sensitivity assay, cell proliferation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — enzymatic activity assay plus Bok KO mouse model, defined functional readout, single lab\",\n      \"pmids\": [\"31311867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Deletion of BOK expression by CRISPR/Cas9 significantly reduces mitochondrial fusion rate, resulting in mitochondrial fragmentation. This fragmentation phenotype is reversed by exogenous wild-type BOK and by an IP3R binding-deficient BOK mutant. BOK deletion also enhances mitochondrial spare respiratory capacity and membrane potential. BOK deletion does not alter IP3R-mediated Ca2+ signaling or Ca2+ influx into mitochondria. BOK deletion does not alter responsiveness to various apoptotic stimuli.\",\n      \"method\": \"CRISPR/Cas9 knockout, mitochondrial morphology analysis, mitochondrial fusion rate assay (photoactivatable GFP), Ca2+ mobilization assay, bioenergetics assay, BOK rescue constructs\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR KO plus multiple orthogonal functional assays plus rescue with domain mutants, single lab, rigorous design\",\n      \"pmids\": [\"30976095\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The transmembrane domain (TMD) of MCL-1 forms homooligomers in the mitochondrial membrane and induces cell death in a BOK-dependent manner. The BOK TMD oligomers localize preferentially to the ER, while heterooligomerization between MCL-1 TMD and BOK TMD occurs predominantly at the mitochondrial membrane. Co-expression of MCL-1 and BOK TMDs increases ER-mitochondrial associated membrane (MAM) contacts. Cancer-associated somatic mutations in MCL-1 TMD alter the TMD interaction pattern.\",\n      \"method\": \"Split-GFP TMD interaction assay, subcellular localization analysis, BOK-dependent cell death assay, molecular dynamics simulation, mutant analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional interaction assay plus molecular dynamics, defined BOK-dependent phenotype, single lab\",\n      \"pmids\": [\"33093207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BOK is necessary for baseline mitochondrial calcium levels and stimulus-induced calcium transfer from the ER to the mitochondria. Bok-/- MEFs have decreased proximity of the ER to the mitochondria and altered protein composition of mitochondria-associated membranes (MAMs). Drug-inducible ER-mitochondria linkers can overcome the proximity defect but fail to rescue thapsigargin-induced calcium transfer or apoptosis in Bok-/- cells. A BOK mutant unable to interact with IP3R restores ER-mitochondrial proximity but not calcium transfer, MAM protein composition, or apoptosis, showing that the BOK-IP3R interaction specifically governs calcium transfer.\",\n      \"method\": \"Bok-/- MEFs, mitochondrial calcium assay, ER-mitochondrial proximity assay (proximity ligation), chemically inducible organelle linkers, BOK IP3R-binding mutant, MAM proteomics, apoptosis assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including inducible linkers and domain-specific mutants, clean KO, functional rescue experiments\",\n      \"pmids\": [\"33691099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Proximity labeling (TurboID-Bok) revealed that Bok is proximal to proteins involved in mitochondrial fission (e.g., Drp1) and ER-plasma membrane junctions (e.g., Stim1). Among BCL-2 family members, Bok is proximal only to Mcl-1. When overexpressed, Mcl-1 and Bok interact physically and functionally in a manner dependent on the transmembrane domain of Bok. The Bok interactome is largely distinct from those of Mcl-1 and Bak.\",\n      \"method\": \"TurboID proximity labeling, mass spectrometry, co-immunoprecipitation, transmembrane domain deletion mutants\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proximity labeling plus Co-IP for physical interaction, TMD dependency shown by mutagenesis, single lab\",\n      \"pmids\": [\"34136494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Bok binds to a largely disordered loop in IP3R1 between α helices 72 and 73 (residues 1882–1957). The high-affinity binding site maps to amino acids 1898–1940 (Kd ~65 nM as measured with purified proteins and IP3R1-derived peptides). Binding is mediated by multivalent interactions with both the central low-disorder region and flanking high-disorder regions. Small deletions in the predicted transient helical elements (residues ~1914–1926) block Bok binding.\",\n      \"method\": \"Bioinformatic disorder prediction, in vitro pulldown with purified Bok and IP3R1 peptides, IP3R1 deletion/point mutants, membrane recruitment assay in cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified proteins, Kd measurement, mutagenesis, multiple orthogonal methods in one study\",\n      \"pmids\": [\"33773141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SARS-CoV-2 membrane (M) protein stabilizes BOK by inhibiting its ubiquitination and promotes BOK mitochondrial translocation. The endodomain of M protein is required for interaction with BOK. The BH2 domain of BOK is required for interaction with M protein and for pro-apoptotic activity. M protein can induce MOMP-independent apoptosis via BOK in the absence of BAX and BAK. BOK knockout (CRISPR) increases cellular resistance to M protein-induced apoptosis; BOK re-expression restores it.\",\n      \"method\": \"CRISPR/Cas9 BOK knockout, co-immunoprecipitation, ubiquitination assay, domain deletion mutants, apoptosis assay in BAX/BAK-deficient cells, in vivo lentiviral infection model\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, ubiquitination assay, CRISPR KO rescue, domain mutants, and in vivo validation in a single study\",\n      \"pmids\": [\"35022571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BOK-deficient cells have an attenuated unfolded protein response (UPR) across all three UPR signaling branches upon ER stress induction. FRAP experiments with GRP78/BiP-eGFP demonstrated that GRP78 motility is significantly lower in BOK-deficient cells, indicating more BiP is bound to unfolded proteins (reduced chaperone availability), establishing BOK as a regulator of ER proteostasis.\",\n      \"method\": \"UPR reporter cell lines, FRAP microscopy with GRP78-eGFP, Bok-/- neurons and cell lines\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRAP plus functional UPR reporters in KO cells, two orthogonal approaches, single lab\",\n      \"pmids\": [\"36060797\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Endogenous Bok is stable at the ER membrane and its stability is critically dependent on the presence of IP3Rs. In the absence of IP3Rs, endogenous Bok is rapidly degraded by the ubiquitin-proteasome pathway. Proteasome inhibitor-induced apoptosis is not mediated by endogenous Bok. Charged residues in the transmembrane region of Bok affect its stability, ability to interact with Mcl-1, and pro-apoptotic activity when over-expressed. This study reports that endogenous Bok does not play a major role in apoptotic signaling (negative finding regarding BOK as a constitutively active MOMP effector governed purely by proteasomal degradation).\",\n      \"method\": \"IP3R knockout cells, proteasome inhibition, ubiquitylation assay, Bok stability assays, transmembrane domain mutants, apoptosis assays\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — IP3R KO plus mutagenesis plus proteasome inhibition, multiple orthogonal approaches, single lab\",\n      \"pmids\": [\"36601536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The transmembrane domain (TMD) of anti-apoptotic BCL-2 interacts with the TMD of BOK at the ER membrane, as demonstrated by split-luciferase assay in living cells and confirmed by molecular dynamics simulations showing stable BOK-TMD/BCL-2-TMD heterotetramers. Mutation of BCL-2-TMD at predicted key residues abolishes interaction with BOK-TMD. Inhibition of BOK-induced apoptosis by BCL-2 depends specifically on their TMD interaction, revealing a novel TMD-mediated apoptosis regulation mechanism.\",\n      \"method\": \"Split luciferase assay in living cells, molecular dynamics simulation, site-directed mutagenesis of BCL-2-TMD, subcellular localization, apoptosis assay\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — reconstitution of TMD interaction in cells, MD simulation structural validation, mutagenesis, functional apoptosis assay, multiple orthogonal methods\",\n      \"pmids\": [\"39048751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"BOK directly suppresses IP3R1-mediated Ca2+ mobilization. Specifically, Bok accelerates the post-maximal decline in GPCR-induced cytosolic Ca2+ by suppressing IP3R-dependent Ca2+ release from the ER. This effect requires the Bok-IP3R interaction (only seen with IP3Rs that bind Bok, e.g., IP3R1). Ser-8 phosphorylation of BOK by cAMP-dependent protein kinase weakens Bok-IP3R1 interaction and reverses Bok's suppressive effect on IP3R1-mediated Ca2+ mobilization.\",\n      \"method\": \"Fluorescent Ca2+-sensitive dye and genetically encoded Ca2+ sensor assays, PKA phosphorylation of purified proteins, mass spectrometry, phosphomimetic substitution (Ser-8), GPCR agonist stimulation, IP3R1-expressing cell systems\",\n      \"journal\": \"Cell communication and signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro PKA assay with purified proteins plus multiple functional Ca2+ assays in cells plus phosphomimetic mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"39810210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BOK expression is negatively regulated post-transcriptionally by TRIM28 binding to conserved AU/U-rich elements in the human BOK 3' UTR. TRIM28 was identified as a key regulatory component by proteomics approaches, and its recruitment to the 3' UTR results in dramatic reduction of BOK expression.\",\n      \"method\": \"Proteomics/mass spectrometry identification, RNA pulldown, reporter assay, TRIM28 knockdown\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteomic identification plus functional RNA pulldown and reporter assay, single lab\",\n      \"pmids\": [\"30471638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"miR-296-5p regulates BOK expression by binding to its 3' UTR in breast cancer cells. Ectopic BOK expression induces MCL-1 upregulation, while MCL-1 silencing reduces BOK levels, forming a regulatory feedback loop. Glycogen synthase kinase (GSK3) α/β interacts with BOK and regulates its protein level post-translationally.\",\n      \"method\": \"3'-UTR luciferase reporter assay, co-immunoprecipitation (GSK3-BOK), BOK/MCL-1 siRNA knockdown, Western blot\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — 3'-UTR reporter plus Co-IP, multiple interactions identified but single lab with limited mechanistic depth per interaction\",\n      \"pmids\": [\"29156771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"BCL-B interacts directly with BOK and can mitigate BOK-mediated cell death. This interaction promotes sublethal MOMP, generating apoptosis-flatliners that serve as drug-tolerant persister cells with enhanced invasiveness via EMT.\",\n      \"method\": \"Co-immunoprecipitation, sublethal MOMP assay, apoptosis-flatliner identification, EMT assay\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP plus functional assays, single lab, limited mechanistic detail in abstract\",\n      \"pmids\": [\"39996719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"BOK interacts with and increases UMPS enzymatic activity to promote UMP synthesis. BOK deficiency increases baseline DNA damage and p53 activation. In p53-deficient NSCLC cells, BOK loss elevates DNA damage and increases dependence on ATR-mediated repair, creating a synthetic lethal interaction with the ATR inhibitor ceralasertib. The DNA damage in BOK-deficient cells was rescued by a cell-permeable BOK-BH3-derived peptide, linking BOK's effect on genomic stability to its UMPS-regulatory function.\",\n      \"method\": \"UMPS activity assay, Bok-deficient NSCLC cell lines, ATR inhibitor (ceralasertib) treatment, DNA damage markers, BOK-BH3 peptide rescue, p53-deficient cell models\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — enzymatic assay plus peptide rescue plus synthetic lethality in multiple cell models, single lab\",\n      \"pmids\": [\"41611842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"EGR3 is a transcription factor that directly binds to the BOK gene promoter to transcriptionally activate BOK expression, as demonstrated by ChIP and dual luciferase reporter assays. BOK promotes mitochondrial apoptosis in response to arsenic exposure downstream of EGR3.\",\n      \"method\": \"ChIP, dual luciferase reporter assay, EGR3/BOK overexpression/knockdown, apoptosis assay\",\n      \"journal\": \"Phytomedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assay identifies direct transcriptional regulation, single lab\",\n      \"pmids\": [\"42097002\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BOK is a BCL-2 family effector protein that primarily localizes to the ER and Golgi membranes via a C-terminal tail-anchor, where it constitutively binds IP3Rs (preferentially IP3R1/2) at a defined coupling-domain site to suppress IP3R-mediated Ca2+ release—a function reversed by PKA-mediated Ser-8 phosphorylation; BOK promotes ER-mitochondria contact site proximity and calcium transfer required for ER stress-induced apoptosis, regulates mitochondrial fusion/morphology and bioenergetics, and enhances UMPS activity to support uridine biosynthesis and genomic stability; BOK protein stability is governed by AMFR/gp78-mediated ubiquitylation and VCP/p97-dependent proteasomal degradation (which is itself counteracted by IP3R binding), and BOK can act as a non-canonical, intrinsically metastable effector of MOMP independently of BAX and BAK when stabilized, with its pro-apoptotic activity regulated through both BH3-groove and transmembrane-domain interactions with anti-apoptotic partners (selectively Mcl-1, Bfl-1, BHRF1, and BCL-2 via TMD).\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BOK is a pro-apoptotic BCL-2 family effector that links endoplasmic reticulum/Golgi membrane biology to mitochondrial outer membrane permeabilization (MOMP) and intrinsic apoptosis [#0, #5, #9]. It was originally defined by a BH1/BH2/BH3-domain architecture lacking BH4 and a selective heterodimerization pattern with anti-apoptotic Mcl-1, Bfl-1, and BHRF1 but not Bcl-2, Bcl-xL, or Bcl-w [#0]. Endogenous BOK is tail-anchored at the ER and Golgi membranes [#5], where it binds strongly and constitutively to inositol-1,4,5-trisphosphate receptors, preferring IP3R1/IP3R2, through a high-affinity site within the largely disordered IP3R1 coupling-domain loop (residues ~1898–1940) [#6, #24]. Through this interaction BOK suppresses IP3R-mediated Ca2+ release—an inhibition relieved by PKA-mediated Ser-8 phosphorylation that weakens BOK–IP3R1 binding [#29]—and establishes ER–mitochondria proximity and the ER-to-mitochondria Ca2+ transfer required for ER-stress-induced apoptosis [#22]. Consistent with this ER-centric role, Bok-deficient cells are selectively defective in apoptosis triggered by ER stressors and show an attenuated unfolded protein response and reduced chaperone availability [#8, #26]. BOK can act as a non-canonical MOMP effector that triggers cytochrome c release independently of BAX and BAK; its activity is metastability-driven rather than dependent on activator BH3 ligands, and a stabilizing helix-α1 glycine substitution inhibits permeabilization [#9, #15]. BOK is held at low abundance by AMFR/gp78-mediated ubiquitylation and VCP/p97-dependent proteasomal degradation, with IP3R binding stabilizing the protein, so that stabilization (by proteasome/VCP/gp78 impairment or loss of degradation machinery) permits BOK-driven apoptosis [#9, #27]. Beyond cell death, BOK promotes mitochondrial fusion and regulates mitochondrial morphology and bioenergetics [#11, #20], and it enhances uridine monophosphate synthetase (UMPS) activity to support uridine biosynthesis, chemosensitivity to 5-fluorouracil, and genomic stability [#19, #33]. Its pro-apoptotic activity is restrained by anti-apoptotic partners through both BH3-groove and transmembrane-domain interactions, the latter mediating selective inhibition by MCL-1 and by BCL-2 at the ER membrane [#18, #28].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established BOK as a distinct pro-apoptotic BCL-2 family member, defining its domain content and an unusual selective binding to a subset of anti-apoptotic proteins.\",\n      \"evidence\": \"Yeast two-hybrid screening and mammalian overexpression/rescue assays\",\n      \"pmids\": [\"9356461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address endogenous localization or physiological function\", \"Heterodimerization specificity not mapped to structural determinants\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed heterodimerization with anti-apoptotic proteins is dispensable for BOK killing, decoupling its pro-apoptotic activity from BH3-mediated binding.\",\n      \"evidence\": \"Splice-variant and BH3 mutagenesis with in vitro binding and cell-death assays\",\n      \"pmids\": [\"9804769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of killing independent of dimerization not defined\", \"Endogenous relevance of the splice variant not established\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Placed BOK in the p53-dependent DNA-damage apoptosis pathway upstream of cytochrome c release.\",\n      \"evidence\": \"p53 activation, protein-synthesis inhibition, and cytochrome c translocation assays in tumor cells\",\n      \"pmids\": [\"15102863\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No BOK knockout validation of the requirement\", \"Direct vs indirect role in cytochrome c release unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified transcriptional (E2F) and post-translational (Crm1-mediated nuclear export) controls on BOK abundance and localization.\",\n      \"evidence\": \"ChIP/luciferase promoter analysis and leptomycin B/Co-IP localization studies\",\n      \"pmids\": [\"16772296\", \"16302269\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of nuclear BOK pool unclear\", \"Cell-cycle coupling of BOK function not demonstrated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined BOK as a tail-anchored ER/Golgi membrane protein that constitutively binds IP3R1/2 at a discrete coupling-domain site and protects IP3Rs from proteolysis.\",\n      \"evidence\": \"Subcellular fractionation, microscopy, reciprocal Co-IP, domain mapping, and protease-protection assays\",\n      \"pmids\": [\"23429263\", \"23884412\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of IP3R binding for Ca2+ signaling not yet measured\", \"Relationship between membrane localization and MOMP activity unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrated in vivo that BOK overlaps functionally with BAX (not BAK) in physiological apoptosis using compound knockout mice.\",\n      \"evidence\": \"Bok/Bax and Bok/Bak compound knockout mice with ovarian histology\",\n      \"pmids\": [\"23744350\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of BAX-overlap not defined\", \"Tissue specificity of overlapping function not generalized\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established a selective, non-redundant requirement for BOK in ER-stress-induced apoptosis that BAX and BAK cannot compensate.\",\n      \"evidence\": \"Bok-/- MEFs challenged with multiple ER stressors plus UPR readouts and in vivo challenge\",\n      \"pmids\": [\"26015568\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic link between ER localization and apoptotic execution not yet defined\", \"Whether the effect requires IP3R binding untested at this stage\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined BOK as a constitutively active, BAX/BAK-independent MOMP effector whose activity is governed primarily by gp78/VCP-dependent proteasomal degradation.\",\n      \"evidence\": \"BAX/BAK-DKO cells, ubiquitylation assays, gp78/VCP knockdown, and MOMP/apoptosis readouts\",\n      \"pmids\": [\"26949185\", \"27076518\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endogenous BOK acts this way under physiological conditions later contested\", \"Structural basis of constitutive activity not resolved here\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Revealed a non-apoptotic, MCL-1-dependent role for BOK in neuronal mitochondrial bioenergetics and calcium homeostasis under metabolic stress.\",\n      \"evidence\": \"Bok-/- neurons with calcium imaging, bioenergetics, MCL-1 rescue, and in vivo seizure/ischemia models\",\n      \"pmids\": [\"27098698\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which BOK maintains MCL-1 levels unclear\", \"Connection between bioenergetic and apoptotic roles not unified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Mapped multiple layers of BOK abundance control: post-transcriptional repression by TRIM28 and miR-296-5p, ER-associated DNAJB12/gp78 turnover, and a MAL/MRTF-SRF transcriptional input.\",\n      \"evidence\": \"RNA pulldown/reporter assays, Co-IP of degradation complexes, and ChIP/reporter promoter analysis\",\n      \"pmids\": [\"28536268\", \"30471638\", \"29156771\", \"22185759\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of each regulatory layer in vivo unknown\", \"Integration of transcriptional and degradative control not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Tested BOK's intrinsic membrane-permeabilizing activity, showing it forms toroidal pores in liposomes but fails to permeabilize native BAX/BAK-null mitochondria.\",\n      \"evidence\": \"Recombinant BOKΔC liposome and isolated-mitochondria permeabilization assays with cBID/BCL-XL\",\n      \"pmids\": [\"28064468\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Additional factors required for mitochondrial activity unidentified\", \"Negative mitochondrial result leaves native mechanism unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Provided a structural basis for BOK activation as a metastability-driven process distinct from BH3-ligand-driven BAX/BAK activation.\",\n      \"evidence\": \"NMR structure of the BOK BCL-2 core, stability/denaturation assays, mutagenesis, and reconstituted MOMP\",\n      \"pmids\": [\"29768206\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological trigger that exposes the metastable conformation unknown\", \"Structure of full-length membrane-embedded BOK not determined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Confirmed structural similarity to BAX/BAK and demonstrated overlapping developmental cell-death function in triple-knockout mice.\",\n      \"evidence\": \"Structural comparison and Bok/Bax/Bak triple-knockout developmental phenotyping\",\n      \"pmids\": [\"29775594\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-level mechanism of the developmental requirement undefined\", \"Quantitative contribution of BOK vs BAX/BAK not parsed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Localized inhibition of BOK by anti-apoptotic proteins to both BH3-groove and transmembrane-domain interactions, especially with MCL-1, and revealed BOK's role in CER-driven mitochondrial fission.\",\n      \"evidence\": \"Domain-deletion/mutagenesis apoptosis and interaction assays; gain/loss-of-function fission assays with DRP1/MFN2 readouts\",\n      \"pmids\": [\"30127460\", \"29463805\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TMD interaction structure not resolved in these studies\", \"Mechanistic link between BOK and DRP1/MFN2 regulation unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Uncovered two non-canonical BOK functions: positive regulation of UMPS-driven uridine biosynthesis/5-FU sensitivity and promotion of mitochondrial fusion.\",\n      \"evidence\": \"Bok-/- cells/mice with UMPS activity and 5-FU sensitivity assays; CRISPR-KO mitochondrial fusion-rate, bioenergetics, and rescue with IP3R-binding-deficient mutant\",\n      \"pmids\": [\"31311867\", \"30976095\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which BOK enhances UMPS activity not defined\", \"How fusion regulation relates to IP3R binding only partially separated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed transmembrane-domain heterooligomerization between MCL-1 and BOK occurs at mitochondria and modulates MAM contacts and BOK-dependent death.\",\n      \"evidence\": \"Split-GFP TMD interaction assay, localization analysis, MD simulation, and BOK-dependent death readouts\",\n      \"pmids\": [\"33093207\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural detail of TMD heterooligomers limited to simulation\", \"Physiological stoichiometry of TMD complexes unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated that the BOK–IP3R interaction specifically governs ER-to-mitochondria Ca2+ transfer and MAM composition required for ER-stress apoptosis, separable from mere organelle proximity.\",\n      \"evidence\": \"Bok-/- MEFs, proximity ligation, inducible ER-mitochondria linkers, IP3R-binding mutant rescue, and MAM proteomics\",\n      \"pmids\": [\"33691099\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of MAM proteins functionally dependent on BOK not fully resolved\", \"How Ca2+ transfer couples to MOMP execution undefined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Refined the BOK proximal interactome, confirming proximity to fission (Drp1) and ER-PM (Stim1) machinery and a TMD-dependent physical interaction with MCL-1 distinct from BAK.\",\n      \"evidence\": \"TurboID proximity labeling/MS, Co-IP, and TMD-deletion mutants\",\n      \"pmids\": [\"34136494\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of most proximal partners untested\", \"Endogenous vs overexpression interactome differences not parsed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined the BOK–IP3R1 binding interface at atomic detail, showing high-affinity multivalent binding to a disordered IP3R1 loop.\",\n      \"evidence\": \"Disorder prediction, in vitro pulldown with purified proteins/peptides, Kd measurement, and mutagenesis\",\n      \"pmids\": [\"33773141\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"BOK surface mediating binding not co-mapped here\", \"Whether binding alters IP3R channel gating not tested in this study\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established IP3R binding as the dominant determinant of endogenous BOK stability and challenged the model of endogenous BOK as a proteasome-controlled constitutive MOMP effector.\",\n      \"evidence\": \"IP3R-knockout cells, proteasome inhibition, ubiquitylation and stability assays, and TMD mutants\",\n      \"pmids\": [\"36601536\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reconciliation with gp78/VCP degradation model incomplete\", \"Context determining when endogenous BOK is apoptotically active unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked BOK to ER proteostasis by showing it sustains the unfolded protein response and chaperone availability.\",\n      \"evidence\": \"UPR reporter cells and FRAP of GRP78/BiP-eGFP in Bok-deficient cells/neurons\",\n      \"pmids\": [\"36060797\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which BOK modulates BiP/UPR not defined\", \"Whether the effect requires IP3R binding untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified BOK as a host target hijacked by SARS-CoV-2 M protein to drive BAX/BAK-independent apoptosis via inhibition of BOK ubiquitination.\",\n      \"evidence\": \"CRISPR-KO/rescue, Co-IP, ubiquitination and domain-deletion assays, and in vivo lentiviral model\",\n      \"pmids\": [\"35022571\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generalizability beyond M protein to other viral contexts unknown\", \"BH2-domain interaction interface not structurally resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrated direct functional suppression of IP3R1-mediated Ca2+ mobilization by BOK and identified PKA Ser-8 phosphorylation as a switch reversing this suppression.\",\n      \"evidence\": \"Ca2+ sensor assays with GPCR stimulation, in vitro PKA phosphorylation of purified proteins, MS, and phosphomimetic mutagenesis\",\n      \"pmids\": [\"39810210\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals controlling PKA-dependent BOK phosphorylation unknown\", \"Physiological settings where this switch operates undefined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolved a TMD-mediated mechanism by which anti-apoptotic BCL-2 inhibits BOK at the ER membrane.\",\n      \"evidence\": \"Split-luciferase TMD interaction in cells, MD simulation of heterotetramers, BCL-2-TMD mutagenesis, and apoptosis assays\",\n      \"pmids\": [\"39048751\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural model rests on simulation rather than experimental structure\", \"Relative contribution of TMD vs BH3-groove inhibition in cells not quantified\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Connected BOK's UMPS-regulatory activity to genomic stability, creating an ATR-inhibitor synthetic lethality in p53-deficient cancer cells, and identified additional transcriptional and protein-stability regulators.\",\n      \"evidence\": \"UMPS activity assays, Bok-deficient NSCLC cells with ATR inhibitor, BOK-BH3 peptide rescue, and EGR3 ChIP/reporter analysis\",\n      \"pmids\": [\"41611842\", \"42097002\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of BOK-UMPS activation still undefined\", \"Direct mechanism linking UMP synthesis to DNA-damage prevention incomplete\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How BOK integrates its ER/IP3R-bound Ca2+-regulatory role, its metastable MOMP-effector activity, and its non-apoptotic metabolic and mitochondrial-dynamics functions into a single physiological program remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of full-length, membrane-embedded or IP3R-bound BOK\", \"The physiological trigger that converts stable ER-resident BOK into an active MOMP effector is unknown\", \"Whether the UMPS/uridine and apoptotic functions are mechanistically linked is undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [6, 22, 29]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [19, 33]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [9, 12, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [5, 6, 8, 22, 27]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [9, 11, 20, 21, 25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 9, 16]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [8, 26]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [19, 33]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ITPR1\", \"ITPR2\", \"MCL1\", \"BCL2\", \"AMFR\", \"VCP\", \"DNAJB12\", \"UMPS\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}